<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS Pathog</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-title-group>
      <journal-title>PLoS Pathogens</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1553-7366</issn>
    <issn pub-type="epub">1553-7374</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9262239</article-id>
    <article-id pub-id-type="doi">10.1371/journal.ppat.1010602</article-id>
    <article-id pub-id-type="publisher-id">PPATHOGENS-D-22-00601</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Review</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Organisms</subject>
          <subj-group>
            <subject>Viruses</subject>
            <subj-group>
              <subject>Bacteriophages</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Organisms</subject>
          <subj-group>
            <subject>Bacteria</subject>
            <subj-group>
              <subject>Actinobacteria</subject>
              <subj-group>
                <subject>Mycobacterium Tuberculosis</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Organisms</subject>
          <subj-group>
            <subject>Bacteria</subject>
            <subj-group>
              <subject>Actinobacteria</subject>
              <subj-group>
                <subject>Mycobacteria</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Medical Microbiology</subject>
            <subj-group>
              <subject>Microbial Pathogens</subject>
              <subj-group>
                <subject>Bacterial Pathogens</subject>
                <subj-group>
                  <subject>Mycobacteria</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Pathology and Laboratory Medicine</subject>
          <subj-group>
            <subject>Pathogens</subject>
            <subj-group>
              <subject>Microbial Pathogens</subject>
              <subj-group>
                <subject>Bacterial Pathogens</subject>
                <subj-group>
                  <subject>Mycobacteria</subject>
                </subj-group>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Genomics</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>Genomics</subject>
            <subj-group>
              <subject>Microbial Genomics</subject>
              <subj-group>
                <subject>Viral Genomics</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Microbial Genomics</subject>
            <subj-group>
              <subject>Viral Genomics</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Virology</subject>
            <subj-group>
              <subject>Viral Genomics</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immunity</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Immunology</subject>
          <subj-group>
            <subject>Immunity</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Genetics</subject>
          <subj-group>
            <subject>DNA</subject>
            <subj-group>
              <subject>DNA recombination</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and life sciences</subject>
        <subj-group>
          <subject>Biochemistry</subject>
          <subj-group>
            <subject>Nucleic acids</subject>
            <subj-group>
              <subject>DNA</subject>
              <subj-group>
                <subject>DNA recombination</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Biology and Life Sciences</subject>
        <subj-group>
          <subject>Microbiology</subject>
          <subj-group>
            <subject>Virology</subject>
            <subj-group>
              <subject>Viral Replication</subject>
              <subj-group>
                <subject>Lysogeny</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Mycobacteriophages: From Petri dish to patient</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6705-6821</contrib-id>
        <name>
          <surname>Hatfull</surname>
          <given-names>Graham F.</given-names>
        </name>
        <xref rid="cor001" ref-type="corresp">*</xref>
        <xref rid="aff001" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <addr-line>Department of Biological Sciences, University of Pittsburgh, Pittsburgh, United States of America</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Blumenthal</surname>
          <given-names>Antje</given-names>
        </name>
        <role>Editor</role>
        <xref rid="edit1" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>University of Queensland, AUSTRALIA</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p>I have read the journal’s policy and have the following conflicts: I receive research support from Janssen Pharmaceuticals, and am a consultant for Tessera Inc. and Janssen.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>gfh@pitt.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>7</day>
      <month>7</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <month>7</month>
      <year>2022</year>
    </pub-date>
    <volume>18</volume>
    <issue>7</issue>
    <elocation-id>e1010602</elocation-id>
    <permissions>
      <copyright-statement>© 2022 Graham F. Hatfull</copyright-statement>
      <copyright-year>2022</copyright-year>
      <copyright-holder>Graham F. Hatfull</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="ppat.1010602.pdf"/>
    <abstract>
      <p>Mycobacteriophages—bacteriophages infecting <italic toggle="yes">Mycobacterium</italic> hosts—contribute substantially to our understanding of viral diversity and evolution, provide resources for advancing <italic toggle="yes">Mycobacterium</italic> genetics, are the basis of high-impact science education programs, and show considerable therapeutic potential. Over 10,000 individual mycobacteriophages have been isolated by high school and undergraduate students using the model organism <italic toggle="yes">Mycobacterium smegmatis</italic> mc<sup>2</sup>155 and 2,100 have been completely sequenced, giving a high-resolution view of the phages that infect a single common host strain. The phage genomes are revealed to be highly diverse and architecturally mosaic and are replete with genes of unknown function. Mycobacteriophages have provided many widely used tools for <italic toggle="yes">Mycobacterium</italic> genetics including integration-proficient vectors and recombineering systems, as well as systems for efficient delivery of reporter genes, transposons, and allelic exchange substrates. The genomic insights and engineering tools have facilitated exploration of phages for treatment of <italic toggle="yes">Mycobacterium</italic> infections, although their full therapeutic potential has yet to be realized.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000057</institution-id>
            <institution>National Institute of General Medical Sciences</institution>
          </institution-wrap>
        </funding-source>
        <award-id>GM131729</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6705-6821</contrib-id>
          <name>
            <surname>Hatfull</surname>
            <given-names>Graham F.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <award-group id="award002">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000011</institution-id>
            <institution>Howard Hughes Medical Institute</institution>
          </institution-wrap>
        </funding-source>
        <award-id>GT12053</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6705-6821</contrib-id>
          <name>
            <surname>Hatfull</surname>
            <given-names>Graham F.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>This work was supported by grants from the National Institutes of Health grant GM131729 (GFH) and the Howard Hughes Medical Institute Grant GT12053 (GFH). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="4"/>
      <table-count count="0"/>
      <page-count count="25"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="sec001">
    <title>Why study phages and mycobacteriophages in particular?</title>
    <p>Bacteriophages were discovered a little over a hundred years ago and quickly developed into workhorses for molecular biology and genetics [<xref rid="ppat.1010602.ref001" ref-type="bibr">1</xref>]. They provided suitably sized genomes for development of early DNA sequencing techniques, although phage genomics did not really take off until the early 1990s. Mycobacteriophages—the subject of this review—became a focus of interest for addressing 5 key priorities. First, is the deep exploration of phages that infect a single common host strain (<italic toggle="yes">Mycobacterium smegmatis</italic> mc<sup>2</sup>155) for insights into viral diversity, evolution, and origins? Second, is the use of phage discovery and genomics as a platform for advancing science education? Third, is the investigation of all aspects of host–phage dynamics, including host range, life cycle regulation, viral defense, and counterdefense? Fourth, is the exploitation of mycobacteriophage genomes to develop tools for simplifying and advancing <italic toggle="yes">Mycobacterium</italic> genetics? Lastly, is the potential for clinical use of mycobacteriophages to control <italic toggle="yes">Mycobacterium</italic> diseases? I will provide introductory information for the general reader on the world of bacteriophages and will then discuss recent advances toward these 5 priorities.</p>
  </sec>
  <sec id="sec002">
    <title>Introduction to the phage world</title>
    <p>Bacteriophages are viruses that infect bacteria. They are prevalent in the environment and throughout the human body, and there are an estimated 10<sup>31</sup> phage particles in total in the biosphere, making them the majority of all biological entities [<xref rid="ppat.1010602.ref002" ref-type="bibr">2</xref>–<xref rid="ppat.1010602.ref004" ref-type="bibr">4</xref>]. The phage population is old—plausibly originating over 3 billion years ago—and is highly dynamic. Phages are constantly infecting bacterial hosts, replicating, and replenishing the population, and there is estimated to be about 10<sup>23</sup> phage infections per second, with the phage population replacing itself every few days [<xref rid="ppat.1010602.ref004" ref-type="bibr">4</xref>].</p>
    <p>Given these parameters, it is not surprising that phages are genomically highly diverse [<xref rid="ppat.1010602.ref005" ref-type="bibr">5</xref>]. Phage lytic infections—those resulting in replication and production of new phage particles—kill the bacterial host, and there is strong selection for development of resistance and survival. Such mechanisms are widespread and include receptor variation, restriction-modification systems, and CRISPR-Cas arrays among a large variety of newly discovered systems [<xref rid="ppat.1010602.ref006" ref-type="bibr">6</xref>]. Phages would not exist if they could not circumvent these defenses and resistance mechanisms, and they actively coevolve along with their hosts [<xref rid="ppat.1010602.ref007" ref-type="bibr">7</xref>]. They do so by a variety of mechanisms including the acquisition of counterdefenses or switching to a new bacterial host that lacks the defenses. These dynamics have prominently shaped microbial evolution.</p>
    <p>Bacteriophages can use DNA or RNA as their genetic material, which is typically encapsulated in a protein shell, sometimes with lipid components [<xref rid="ppat.1010602.ref008" ref-type="bibr">8</xref>]. A variety of morphologies can be seen by electron microscopy, although the predominant types are those with a tail attached to a capsid (or phage head) containing double-stranded DNA (dsDNA) [<xref rid="ppat.1010602.ref009" ref-type="bibr">9</xref>]. These dsDNA tailed phages (the <italic toggle="yes">Caudovirales</italic>) can be divided into 3 families depending on their tails: the <italic toggle="yes">Myoviridae</italic> with contractile tails; the <italic toggle="yes">Siphoviridae</italic> with long, flexible, noncontractile tails; and the <italic toggle="yes">Podoviridae</italic> with short stubby tails. The capsids are usually isometric (soccer ball-like) or prolate (elongated, rod-like) and vary in size according to the length of the DNA packaged within them. The virion genome is typically linear but may genetically be either linear or circular depending on the DNA packaging mechanism [<xref rid="ppat.1010602.ref010" ref-type="bibr">10</xref>]. Phages using <italic toggle="yes">cos</italic>-type packaging signals have genomes with defined physical ends such that all phage particles have the same genome termini. In contrast, phages using headful DNA packaging systems have genomes that are circularly permuted and terminally redundant, with the physical genome ends different in each particle.</p>
    <p>A key phage property is host specificity. Phage host ranges vary considerably, but it is uncommon for any given phage to infect bacteria in more than one genus. In the few instances where host range spans different genera, the bacteria are usually phylogenetically closely related [<xref rid="ppat.1010602.ref011" ref-type="bibr">11</xref>,<xref rid="ppat.1010602.ref012" ref-type="bibr">12</xref>]. Sometimes host range is restricted to a few strains within a species, and some phages infect only a single known bacterial strain.</p>
    <p>Finally, phages typically can be ascribed to having one of 2 lifestyles, either lytic or temperate. The key distinction is that temperate phages can establish lysogeny within a host cell, whereas lytic phages do not. Both lytic and temperate phages can undergo cycles of lytic growth in which the phage replicates, the cell dies, and progeny phage particles are released. However, this is the sole outcome for a lytic phage (a canonical example is phage T4 of <italic toggle="yes">Escherichia coli</italic>). In contrast, temperate phages can enter one of 2 life cycles upon infection: lytic growth as described above, or lysogeny in which the lytic genes are switched off (a canonical example is phage lambda of <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic>); a prophage is established either by chromosomal integration or plasmidial extrachromosomal replication, and the lysogenic cell continues to grow. The frequency of lysogeny varies enormously depending on various parameters (e.g., growth state, multiplicity of infection), and can be as low as a few percent, or greater than 50% of infections. The prevalence of temperate phages varies depending on the host, and this is reflected in the richness of resident prophages in sequenced bacterial genomes [<xref rid="ppat.1010602.ref013" ref-type="bibr">13</xref>]. It should be noted that some types of temperate phages do not lyse the host cell when replicating, including filamentous phages (inoviruses) such as <italic toggle="yes">Pseudomonas</italic> phage Pf [<xref rid="ppat.1010602.ref014" ref-type="bibr">14</xref>].</p>
  </sec>
  <sec id="sec003">
    <title>Mycobacteriophages are viruses of mycobacteria</title>
    <p>Mycobacteriophages are phages that infect <italic toggle="yes">Mycobacterium</italic> hosts. The genus <italic toggle="yes">Mycobacterium</italic> includes several important human pathogens, including <italic toggle="yes">Mycobacterium tuberculosis</italic>, the causative agent of tuberculosis, and <italic toggle="yes">Mycobacterium avium</italic> complex (MAC) and <italic toggle="yes">Mycobacterium abscessus</italic> complex (MAB) that are notable opportunistic pathogens. Mycobacteria characteristically are acid-fast staining and have unusual cell walls containing mycolic acids, glycolipids, and glycopeptidolipids (GPLs) surrounding the cytoplasmic membrane and peptidoglycan layer. This unusual cell wall presents a unique challenge to bacteriophages that must bind specifically, navigate their tail tips to the membrane, and inject their DNA. At the conclusion of lytic growth, they must also compromise these walls to release progeny phage particles from the cell.</p>
    <p>The first mycobacteriophages were isolated in the 1950s—using <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> as a host—primarily for phage-typing mycobacterial infections, taking advantage of mycobacteriophage host range variations [<xref rid="ppat.1010602.ref015" ref-type="bibr">15</xref>]. Some of these typing phages have been recovered, although others are lost [<xref rid="ppat.1010602.ref016" ref-type="bibr">16</xref>,<xref rid="ppat.1010602.ref017" ref-type="bibr">17</xref>]. The first mycobacteriophage genome to be fully sequenced was that of L5 [<xref rid="ppat.1010602.ref018" ref-type="bibr">18</xref>], which was originally isolated in the 1950s in Japan [<xref rid="ppat.1010602.ref019" ref-type="bibr">19</xref>]. This was followed by reports of genome sequences of phages D29, TM4, and Bxb1 [<xref rid="ppat.1010602.ref020" ref-type="bibr">20</xref>–<xref rid="ppat.1010602.ref022" ref-type="bibr">22</xref>], but further exploration of mycobacteriophage diversity would require additional phage isolation, most prominently using <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> mc<sup>2</sup>155 as a host [<xref rid="ppat.1010602.ref023" ref-type="bibr">23</xref>].</p>
    <sec id="sec004">
      <title>Phage discovery and genomics as integrated research-education programs</title>
      <p>With just a handful of sequenced mycobacteriophages available, in the early 2000s it was clear that gaining a fuller understanding of viral diversity would need a deeper dive into phage isolation and genomic analyses [<xref rid="ppat.1010602.ref024" ref-type="bibr">24</xref>]. An alternative approach—metagenomic analysis of enriched viral samples—is also attractive, but generally provides informative data sets rather than individual phages that can be propagated, engineered, investigated mechanistically, and potentially used translationally. Envisaging the need to isolate phages at substantial scale, we developed integrated research-education programs in which phage discovery and genomics is the primary goal, providing research opportunities to young scientists including high school students and first year undergraduate students [<xref rid="ppat.1010602.ref025" ref-type="bibr">25</xref>]. The Phage Hunters Integrating Research and Education (PHIRE) starting in 2002 provided research experiences locally in Pittsburgh [<xref rid="ppat.1010602.ref026" ref-type="bibr">26</xref>,<xref rid="ppat.1010602.ref027" ref-type="bibr">27</xref>] with the platform expanding into the Science Education Alliance Phage Hunters Advancing Genomics and Evolutionary Science (SEA-PHAGES) in 2008 [<xref rid="ppat.1010602.ref028" ref-type="bibr">28</xref>,<xref rid="ppat.1010602.ref029" ref-type="bibr">29</xref>]; both programs are supported by the Howard Hughes Medical Institute (HHMI). The SEA-PHAGES program has grown with addition of institutions from the United States and beyond, and now has over 170 participating schools with over 5,500 students each year. SEA-PHAGES is an example of an Inclusive Research Education Community (iREC) that encompasses institutions ranging from community colleges to Research I universities and involves all students without pre-selection based on generally irrelevant criteria [<xref rid="ppat.1010602.ref029" ref-type="bibr">29</xref>,<xref rid="ppat.1010602.ref030" ref-type="bibr">30</xref>].</p>
      <p>These programs have produced a massive archive of individual bacteriophages and a rich data set of sequenced and manually annotated genomes focusing on carefully chosen bacterial hosts. The most widely used host is <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> mc<sup>2</sup>155, a natural extension from earlier studies; over 10,000 individual phages have been isolated, by far the deepest investigation of phages using a single bacterial strain. Over 2,000 have been sequenced, and sampling of the remainder suggests that no substantial component of the diversity has been missed. An additional 10,000 phages have been isolated using other bacterial genera within the phylum <italic toggle="yes">Actinobacteria</italic>, including, <italic toggle="yes">Arthrobacter</italic>, <italic toggle="yes">Corynebacterium</italic>, <italic toggle="yes">Gordonia</italic>, <italic toggle="yes">Microbacterium</italic>, <italic toggle="yes">Rhodoccocus</italic>, and <italic toggle="yes">Streptomyces</italic> [<xref rid="ppat.1010602.ref031" ref-type="bibr">31</xref>]. Information about the entire phage collection is available at <ext-link xlink:href="http://phagesdb.org/" ext-link-type="uri">http://phagesdb.org</ext-link>. A genome map of mycobacteriophage Tweety [<xref rid="ppat.1010602.ref032" ref-type="bibr">32</xref>] is shown as an example in <xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref> and illustrates several of the features described below.</p>
      <fig position="float" id="ppat.1010602.g001">
        <object-id pub-id-type="doi">10.1371/journal.ppat.1010602.g001</object-id>
        <label>Fig 1</label>
        <caption>
          <title>Genome organization of Mycobacteriophage Tweety.</title>
          <p>Phage Tweety is a member of Subcluster F1, is temperate, has a siphoviral morphology (inset, electron micropraph; scale marker, 100 nm), and its genome organization illustrates several common features. The genome is represented as a bar with markers every 1 kbp, and the predicted genes are shown as colored boxes above or below the genome, indicating rightwards- and leftwards-transcription, respectively. Gene numbers are shown within the boxes and predicted functions are shown above. The virion structure and assembly genes are arranged in a rightwards-transcribed operon at the left end of the genome (genes 1 to 25), followed by the lysis cassette. The repressor (<italic toggle="yes">45</italic>) and putative Cro-like (<italic toggle="yes">46</italic>) genes are divergently transcribed, and the integration cassette (<italic toggle="yes">attP</italic> and <italic toggle="yes">43</italic>) are located nearby, with <italic toggle="yes">attP</italic> defining a “left arm” from <italic toggle="yes">cos</italic>–<italic toggle="yes">attP</italic> and a “right arm” from <italic toggle="yes">attP–cos</italic>. Note that the left arm genes—predominantly the virion structure and lysis genes—are relatively large and have known functions, whereas the right arm genes are relatively small, and most have unknown functions. Shown are the positions of the MPME mobile element and the counterdefense gene, <italic toggle="yes">54</italic>. The positions of putative early and later lytic promoters as determined by RNAseq are indicated. Note that genes are arranged in long operons such that there are relatively few transcriptional changes (tdc), such as at the <italic toggle="yes">25</italic>/<italic toggle="yes">26</italic> and <italic toggle="yes">45</italic>/<italic toggle="yes">46</italic> junctions.</p>
        </caption>
        <graphic xlink:href="ppat.1010602.g001" position="float"/>
      </fig>
    </sec>
    <sec id="sec005">
      <title>Mycobacteriophage genomics, diversity, and architecture</title>
      <p>What have we learned about mycobacteriophage genomes? Several key themes have emerged. First, the overall diversity is impressive, although complex in its structure. Comparative genomics clearly shows that some phages are closely related, and a system was established early on to accommodate these relationships. Phages that are closely related to each other are grouped into “clusters,” with different phages in different clusters (e.g., Cluster A, Cluster B, Cluster C). Many clusters have recognizable divisions, as seen through average nucleotide identity (ANI) comparisons, and are thus divided into “subclusters” (e.g., Subcluster A1, Subcluster A2, Subcluster A3). Phages for which there are no close relatives are recognized as “singletons”. The initial parameters used for cluster grouping required recognizable nucleotide sequence similarity spanning greater than 50% of the genome lengths, and with only a few dozen genomes all mycobacteriophages could be grouped without any evident challenge to these thresholds [<xref rid="ppat.1010602.ref033" ref-type="bibr">33</xref>–<xref rid="ppat.1010602.ref035" ref-type="bibr">35</xref>].</p>
      <p>As the mycobacteriophage collection grew to several hundred genomes, these “boundaries” of similarity between clusters became fuzzy, with the discovery of phages that only just meet or just miss the thresholds for inclusion in a cluster, or are close to the threshold for inclusion in more than one cluster [<xref rid="ppat.1010602.ref036" ref-type="bibr">36</xref>]. This suggested that the cluster boundaries are artificial and do not reflect hard biological barriers to recombination and exchange of information between phage genomes. Phages therefore appear to form a continuum of diversity but with unequal representation and heterogenous sampling [<xref rid="ppat.1010602.ref036" ref-type="bibr">36</xref>]. This heterogeneity is reflected in the abundance of more than 700 Cluster A phages and more than 350 Cluster B phages, compared to the 7 singletons and 10 clusters with 5 or fewer phage members. As the phage collection continued to expand, the thresholds were redefined with clearer and more quantifiable parameters, and we currently use a threshold of 35% shared gene content (SGC) for cluster inclusion [<xref rid="ppat.1010602.ref037" ref-type="bibr">37</xref>]. This is determined by assorting all of the gene products into groups of related proteins (“phamilies,” or “phams”) using the program Phamerator [<xref rid="ppat.1010602.ref038" ref-type="bibr">38</xref>] and a pipeline based on MMseqs2. This can then be used to determine the number of shared phams, and a tool is available at <ext-link xlink:href="https://phagesdb.org/" ext-link-type="uri">https://phagesdb.org/</ext-link> for simple pairwise SGC comparisons. The overall genomic relationships among the mycobacteriophages can be viewed as a network phylogeny using Splitstree [<xref rid="ppat.1010602.ref039" ref-type="bibr">39</xref>], simplified by using a single representative of each cluster and subcluster together with the 7 singletons (<xref rid="ppat.1010602.g002" ref-type="fig">Fig 2A</xref>). There are numerous examples in which 2 genomes from different clusters (e.g., Bxb1 from Subcluster A1 and Bipper from Cluster Y) have no shared genes at all. There are also examples of phages in different clusters sharing considerable number of genes (e.g., 25% between Fruitloop and Omega in Clusters F and J, respectively). Not surprisingly, there is also considerable intracluster diversity illustrated by the example of the Cluster F phages (<xref rid="ppat.1010602.g002" ref-type="fig">Fig 2B</xref>). There are currently 5 F subclusters (F1 to F5), with by far the vast majority (95%) grouped in Subcluster F1 (<xref rid="ppat.1010602.g002" ref-type="fig">Fig 2B</xref>). Pairwise comparisons show that genomes within Subcluster F1 can share as few as 40% of their genes. In general, the cluster/subcluster/singleton “taxonomy” is of pragmatic use—because of other shared properties—but it is a crude representation of phage diversity.</p>
      <fig position="float" id="ppat.1010602.g002">
        <object-id pub-id-type="doi">10.1371/journal.ppat.1010602.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>Diversity of mycobacteriophage genomes displayed as network phylogenies based on shared gene content.</title>
          <p>(<bold>A</bold>) Relationships among representative members of clusters, subclusters, and singleton genomes. One member of each mycobacteriophage cluster and subcluster together with the 7 singletons were compared using Splitstree [<xref rid="ppat.1010602.ref039" ref-type="bibr">39</xref>] with a nexus file recording the numbers of shared genes. Clusters are illustrated with colored shading; note that some clusters (e.g., Cluster A) contain several subclusters indicated as nodes, whereas other clusters are not subdivided. Singletons are shown as unlabeled black circles. (<bold>B</bold>) Diversity of Cluster F mycobacteriophages. All currently sequenced Cluster F mycobacteriophages (<italic toggle="yes">n</italic> = 188) are displayed as nodes in a network phylogeny using Splitstree. Colored circles show the positions of the Subclusters F2 to F5 genomes; all of the others (<italic toggle="yes">n</italic> = 177) are grouped in Subcluster F1. This illustrates the substantial intracluster diversity, and pairwise comparisons of Subcluster F1 phages show they may share as few as 40% of their genes.</p>
        </caption>
        <graphic xlink:href="ppat.1010602.g002" position="float"/>
      </fig>
      <p>The second key finding is that phage genomes are architecturally mosaic. Each genome is essentially a compilation of modules or mosaic “tiles” that can be assembled in vast numbers of different combinations (see <xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref>) [<xref rid="ppat.1010602.ref023" ref-type="bibr">23</xref>]. These modules are often single genes, and amino acid sequence comparisons reveal many instances of genomes having a shared gene but in different genomic contexts, such that the flanking genes are different. Most commonly, there is a lack of nucleotide sequence similarity and only weak amino acid sequence identity, reflecting relatively old recombination events in phage evolution. The mechanisms giving rise to genome mosaicism are not completely clear, but likely involve non-sequence-directed illegitimate recombination events between genomes [<xref rid="ppat.1010602.ref003" ref-type="bibr">3</xref>,<xref rid="ppat.1010602.ref023" ref-type="bibr">23</xref>]. This is supported by observations of mosaic boundaries between genomes where there is extensive sequence similarity, and the finding that these usually occur at gene—and sometimes domain—boundaries [<xref rid="ppat.1010602.ref003" ref-type="bibr">3</xref>,<xref rid="ppat.1010602.ref004" ref-type="bibr">4</xref>]. Mobile elements such as transposons and homing endonucleases are likely also involved, as well as integrase-mediated site-specific recombination events [<xref rid="ppat.1010602.ref040" ref-type="bibr">40</xref>,<xref rid="ppat.1010602.ref041" ref-type="bibr">41</xref>]. We note that several transposons have been noted in the mycobacteriophage genomes, including the novel small mycobacteriophage mobile elements (MPMEs) first described in Cluster G genomes [<xref rid="ppat.1010602.ref042" ref-type="bibr">42</xref>] (see <xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref>). Phage-encoded homologous recombination systems that can act on short segments of imperfect homology are also implicated in events that can give rise to mosaicism [<xref rid="ppat.1010602.ref043" ref-type="bibr">43</xref>].</p>
      <p>The third key finding is that there are clearly architectural constraints on phage genomes. In general, phage average gene size is smaller (approximately 0.6 kbp) than in bacterial genomes (approximately 1 kbp) [<xref rid="ppat.1010602.ref033" ref-type="bibr">33</xref>], and the genes are assembled into longer operons than in bacteria, so that there are fewer changes in the direction of transcription (tdc) (see <xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref>). The vast majority of mycobacteriophages (in total, and as defined by clusters/subclusters/singletons) have siphoviral morphologies, and these all contain a characteristic operon (approximately typically 20 to 25 kbp) of virion structure and assembly genes (<xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref>). These genes are on average more similar in length to bacterial genes. In contrast, the nonstructural genes in the rest of the genome are much smaller on average, so that there is a bimodal distribution of phage gene length (<xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref>). Genome length varies substantially, and mycobacteriophages with siphoviral morphologies vary from approximately 40 kbp to approximately 110 kbp. Because the genome requirements for virion structure and assembly genes don’t vary greatly, it is the number of nonstructural genes that varies as genome length changes. Some of these genes have predicted functions such as in DNA replication and metabolism, but most are of unknown function (<xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref>). The total number of genes of unknown function among the 2,000 sequenced mycobacteriophages is impressive (&gt;100,000) and suggests that the phage population harbors the greatest reservoir of unexplored gene diversity and function.</p>
    </sec>
    <sec id="sec006">
      <title>Mycobacteriophage lifestyles</title>
      <p><italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> mc<sup>2</sup>155 is prophage-free, but a majority of the mycobacteriophages isolated on this strain are temperate. Specifically, of the 31 clusters and 7 singletons, 21 are temperate or have temperate representatives (Clusters A, E, F, G, I, J, K, L, M, N, P, Q, T, X, Y, Z, and singletons IdentityCrisis, Kumao, LilSpotty, MalagasyRose, and Sparky). It is noteworthy that it is relatively common to isolate phages that have clear plaque morphologies and appear obligatorily lytic but are members of a cluster where most other members are temperate. An early example of this was phage D29 [<xref rid="ppat.1010602.ref020" ref-type="bibr">20</xref>], which is grouped in Subcluster A2 along with temperate phages such as L5 [<xref rid="ppat.1010602.ref018" ref-type="bibr">18</xref>], but has a deletion that removes the repressor gene [<xref rid="ppat.1010602.ref020" ref-type="bibr">20</xref>,<xref rid="ppat.1010602.ref044" ref-type="bibr">44</xref>]. There are many similar examples in other clusters.</p>
      <p>The temperate phages typically encode a repressor that is required for the maintenance of lysogeny (analogous to lambda cI), and an integrase that mediates site-specific integration into the bacterial genome to form a prophage. It is noteworthy though that several phages—all within Cluster A—form extrachromosomal prophage replicons (i.e., plasmidial) and code for <italic toggle="yes">parAB</italic> partitioning systems instead of an integrase [<xref rid="ppat.1010602.ref045" ref-type="bibr">45</xref>]. For many mycobacteriophages (with the notable exception of Cluster A), the repressor gene is centrally located and transcribed divergently from the early lytic genes, with the repressor’s most proximal gene being Cro-like (i.e., analogous to phage lambda Cro). Typically, both repressor and Cro-like proteins contain predicted DNA-binding domains and their genes are separated by an intergenic region of 100 to 300 bp containing promoters for early lytic and repressor gene expression, and an operator site for repressor binding [<xref rid="ppat.1010602.ref046" ref-type="bibr">46</xref>,<xref rid="ppat.1010602.ref047" ref-type="bibr">47</xref>] (see <xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref>). However, few of these repressor or Cro-like proteins have been studied in detail. Two unusual immunity systems warrant further discussion.</p>
    </sec>
    <sec id="sec007">
      <title>Integration-dependent immunity: An atypical system for lysogenic establishment</title>
      <p>First, several mycobacteriophages (including those in Clusters G, N, and P) use an unusual integration-dependent immunity system (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3</xref>) [<xref rid="ppat.1010602.ref046" ref-type="bibr">46</xref>]. In the canonical phage lambda system, establishment of superinfection immunity—prophage repressor expression that prevents superinfection—is distinct from chromosomal integration [<xref rid="ppat.1010602.ref048" ref-type="bibr">48</xref>]. Both are under regulatory control by the cII protein but are separable molecular events. That is, establishment of superinfection immunity (protection from reinfection by particles of the same phage) does not require integration, and integration is not required to establish immunity. In contrast, the integration-dependent immunity systems fundamentally operate differently, and there are several distinguishing and unusual features [<xref rid="ppat.1010602.ref046" ref-type="bibr">46</xref>]. First, the repressor and integrase genes are cotranscribed in an operon, and the attachment site (<italic toggle="yes">attP</italic>) used for integrase-mediated site-specific recombination is within the repressor gene itself (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3A</xref>). This is seemingly paradoxical because integration and prophage formation leads to loss of the 3′ end of the repressor gene, and yet it is the prophage-expressed form of the repressor that needs to be active to confer immunity (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3A</xref>). The resolution of this conundrum is that the virally encoded form of the repressor contains a C-terminal ssrA-like tag that targets it for proteolytic degradation. Integration leads to a C-terminally truncated repressor protein that is stable because of loss of the proteolytic tag, and thus active for superinfection immunity (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3A</xref>). However, this leads to another difficulty. Lysogeny is usually established in only a small proportion of infections (5% to 20%, depending on conditions), and if integration always results in immunity, what prevents all infections from entering lysogeny? The answer is that the integrase protein itself is also under proteolytic control, and similarly carries a C-terminal ssrA-like tag (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3A</xref>). The frequency of lysogeny is therefore likely determined by the activity of host proteases, analogous to the way <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> FtsH determines the activity of lambda cII [<xref rid="ppat.1010602.ref049" ref-type="bibr">49</xref>].</p>
      <fig position="float" id="ppat.1010602.g003">
        <object-id pub-id-type="doi">10.1371/journal.ppat.1010602.g003</object-id>
        <label>Fig 3</label>
        <caption>
          <title>Integration-dependent superinfection immunity systems.</title>
          <p>(A) Typical organization of the immunity regions of phages encoding integration-dependent immunity systems. In the viral genome, the repressor (<italic toggle="yes">rep</italic>) and integrase (<italic toggle="yes">int</italic>) genes are cotranscribed from the P<sub>Rep</sub> promoter, and the phage attachment site (<italic toggle="yes">attP</italic>, blue box) is located within the repressor gene. The virally encoded Integrase and Repressor proteins both carry C-terminal ssrA-like tags (——LAA, or similar) targeting the proteins for proteolytic degradation (red arrows in the int and rep genes; red circles in the proteins; the N-termini are indicated). The virally encoded form of the Repressor is not active in conferring superinfection immunity. The establishment of lysogeny requires integrase-mediated site-specific recombination between the phage <italic toggle="yes">attP</italic> site and a chromosomal <italic toggle="yes">attB</italic> site (which overlaps a host tRNA gene) to form a prophage. Integrative site-specific recombination removes the ssrA-like tag from the repressor and the stable, active form of the repressor binds to the operator (O<sub>R</sub>, yellow box) to shut down the early lytic promoter (P<sub>R</sub>) and confer superinfection immunity. (<bold>B</bold>) Organization of the <italic toggle="yes">attP</italic> and <italic toggle="yes">attB</italic> sites of phage BPs and <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic>. Both DNA strands are shown, and the amino acid sequence of part of the leftwards-transcribed repressor is shown; DNA and protein polarities are indicated. The 35-bp common core sequence (conserved in <italic toggle="yes">attP</italic>, <italic toggle="yes">attB</italic>, <italic toggle="yes">attL</italic>, and <italic toggle="yes">attR</italic>) is boxed, and the region within which strand exchange for recombination must occur is indicated. The codon spanning the left side of the common core is indicated by a red line, and the third position base is shown in bold pink type. The location of the tRNA<sup>arg</sup> gene at <italic toggle="yes">attB</italic> is shown by an arrow; the anticodon is shown in red type. (<bold>C</bold>) Organization of the BPs <italic toggle="yes">attL</italic> site. Conservation of the common sequence between <italic toggle="yes">attP</italic> and <italic toggle="yes">attB</italic> results in construction of an active tRNA<sup>arg</sup> gene when the prophage is established. However, at <italic toggle="yes">attL</italic> the repressor gene encounters a termination codon (TGA) formed at the junction of the bacterial and phage sequences, changing the third base of a cysteine codon (red line) to a nonsense codon; the third position base is shown in bold pink type. (<bold>D</bold>) Alignment of <italic toggle="yes">attP</italic> and <italic toggle="yes">attB</italic> showing the common core (boxed), and the positions of 2 mismatches in the common core, neither of which introduced mispairing in the tRNA<sup>arg</sup> product. Only the top strand of each site is shown.</p>
        </caption>
        <graphic xlink:href="ppat.1010602.g003" position="float"/>
      </fig>
      <p>Like many phages that use integrases of the tyrosine family of site-specific recombinases (i.e., “tyrosine integrases”), all of the phages using integration-dependent immunity systems use an <italic toggle="yes">attB</italic> site overlapping a host tRNA gene (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3B</xref>). The common core sequence—a 35-bp region shared by <italic toggle="yes">attP</italic> and <italic toggle="yes">attB</italic>—must therefore contain not only the sequences for integrase binding and strand cleavage, but also the 3′ end of the tRNA so that tRNA function is maintained in the lysogen (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3B</xref>). Amazingly, the sequences for BPs integration at <italic toggle="yes">attL</italic> not only result in loss of the C-terminal ssrA-like tag from the repressor, but also the bacterium genome sequence base pair immediately adjacent to the common core changes the third position of a cysteine codon in the repressor gene and introduces a translation termination codon (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3C</xref>). In some instances, such as with phage BPs, there are mismatches between the common cores in <italic toggle="yes">attP</italic> and <italic toggle="yes">attB</italic>, although these do not impair normal base paring in the tRNA (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3D</xref>).</p>
      <p>Finally, these integration-dependent immunity systems do not evidently code for a recombination directionality factor (RDF) that normally controls the ratio of integrative and excisive integrase-mediated recombination events [<xref rid="ppat.1010602.ref050" ref-type="bibr">50</xref>]. As such, the frequency of these may simply be determined by the amount of stable integrase in the cell. A consequence of this is that the attachment sites (<italic toggle="yes">attP</italic>, <italic toggle="yes">attL</italic>, <italic toggle="yes">attR</italic>) do not require arm-type integrase binding sites, and only use the common core sequences around the scissile bonds for integrase binding (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3</xref>). It is easy to imagine how this evolved, because <italic toggle="yes">attP</italic> lies within the repressor gene, and an <italic toggle="yes">attP</italic> site the size of that for lambda (250 bp), would impose severe constraints on the amino acid sequence of the repressor (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3</xref>). These types of immunity systems are not only found in mycobacteriophages, but also in a variety of the diverse prophages resident in sequenced <italic toggle="yes">Mycobacterium</italic> genomes [<xref rid="ppat.1010602.ref051" ref-type="bibr">51</xref>].</p>
    </sec>
    <sec id="sec008">
      <title>The repressor–stoperator system of Cluster A mycobacteriophages</title>
      <p>The second system of interest is the repressor–stoperator systems of Cluster A phages. Bioinformatic prediction of repressor genes can be challenging, and the repressors of Cluster A genomes (e.g., L5, Bxb1) were identified using genetic and biochemical methods [<xref rid="ppat.1010602.ref052" ref-type="bibr">52</xref>,<xref rid="ppat.1010602.ref053" ref-type="bibr">53</xref>]. Moreover, the Cluster A repressor genes are situated toward the right end of the genome within a large set of leftwards-transcribed genes and are not closely linked to the centrally located integrase gene. The Cluster A genomes unusually possess many asymmetric 13 to 14 bp sequence motifs located throughout the genome to which the repressor binds [<xref rid="ppat.1010602.ref054" ref-type="bibr">54</xref>,<xref rid="ppat.1010602.ref055" ref-type="bibr">55</xref>]. One of these is a true operator site and overlaps the early lytic promoter, P<sub>left</sub>. The others are referred to as “stoperators,” as they are proposed to be sites where repressor binding results in termination of transcription, rather than inhibition of transcription initiation [<xref rid="ppat.1010602.ref055" ref-type="bibr">55</xref>]. The sites are located primarily within short intergenic regions, are in 1 orientation with respect to the direction of transcription, and confer repressor-dependent orientation-specific down-regulation of a reporter gene [<xref rid="ppat.1010602.ref055" ref-type="bibr">55</xref>]. The presumed function is to silence phage genes in lysogeny and prevent leaky expression that could impose a growth disadvantage to the lysogen [<xref rid="ppat.1010602.ref055" ref-type="bibr">55</xref>]. The immune specificities of the numerous Cluster A phages are highly complex but reveal insights into how these specificities have evolved [<xref rid="ppat.1010602.ref054" ref-type="bibr">54</xref>].</p>
      <p>RNAseq approaches show that many mycobacteriophages display 2 main patterns of lytic gene expression, occurring early (approximately 30 min) and late (approximately 120 min after infection [<xref rid="ppat.1010602.ref044" ref-type="bibr">44</xref>,<xref rid="ppat.1010602.ref056" ref-type="bibr">56</xref>–<xref rid="ppat.1010602.ref058" ref-type="bibr">58</xref>]). Early lytic promoters are often SigA-like, with recognizable −35 and −10 hexamers recognized by the host RNA polymerase and operator sites for repressor binding [<xref rid="ppat.1010602.ref046" ref-type="bibr">46</xref>,<xref rid="ppat.1010602.ref055" ref-type="bibr">55</xref>,<xref rid="ppat.1010602.ref059" ref-type="bibr">59</xref>]. Few late promoters have been characterized, but transcription starts upstream of the virion structure and assembly genes sometimes upstream of the right <italic toggle="yes">cos</italic>-site (<xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref>). Further investigation of the phage late promoters and their regulation is warranted as they are highly active and potentially useful for heterologous gene expression.</p>
    </sec>
    <sec id="sec009">
      <title>Phage integration systems</title>
      <p>Most of the temperate mycobacteriophages encode integration systems similar to those described above for the integration-dependent immunity systems. The integrases can be either lambda-like tyrosine integrases (Int-Y) or large serine-integrases (Int-S), although the former are more common (see <xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref>). At least 14 different <italic toggle="yes">attB</italic> sites have been identified (<xref rid="ppat.1010602.g004" ref-type="fig">Fig 4A</xref>), distributed around the <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> genome. Interestingly, the Int-Y genomes exclusively use <italic toggle="yes">attB</italic> sites overlapping host tRNA genes, and the common core facilitates reconstruction of the tRNA upon integration. Because these common cores are 25 bp or longer, the <italic toggle="yes">attB</italic> site for most Int-Y phages can be predicted using homology searches. This is not so for Int-S phages, for which the common core can be very small (as few as 3 bp), and they do not integrate into tRNA genes [<xref rid="ppat.1010602.ref060" ref-type="bibr">60</xref>–<xref rid="ppat.1010602.ref063" ref-type="bibr">63</xref>]. Their <italic toggle="yes">attB</italic> sites therefore have to be determined experimentally, and Bxb1 and Bxz2 (Subcluster A1 and A3, integrating into attB-7 and attB-4, respectively; <xref rid="ppat.1010602.g004" ref-type="fig">Fig 4A</xref>) have been shown to integrate within the protein-coding genes for <italic toggle="yes">groEL1</italic> (Msmeg_1583) and a putative DNA glycosylase (Msmeg_5156), respectively [<xref rid="ppat.1010602.ref061" ref-type="bibr">61</xref>,<xref rid="ppat.1010602.ref064" ref-type="bibr">64</xref>]. Interestingly, Bxb1 integration inactivates GroEL1 and confers a defect in biofilm formation [<xref rid="ppat.1010602.ref065" ref-type="bibr">65</xref>].</p>
      <fig position="float" id="ppat.1010602.g004">
        <object-id pub-id-type="doi">10.1371/journal.ppat.1010602.g004</object-id>
        <label>Fig 4</label>
        <caption>
          <title>Chromosomal <italic toggle="yes">attB</italic> attachment sites used by temperate phages in <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> and <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic>.</title>
          <p>(<bold>A</bold>) <italic toggle="yes">attB</italic> sites in the <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> mc<sup>2</sup>155 genome. The 7-Mbp <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> genome is represented as a circle with markers at each kbp indicated. The <italic toggle="yes">attB</italic> sites (e.g., attB-1, attB-2, etc.) are shown, together with the genome coordinates in red type; the genes are shown in blue type. The font color of the <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis attB</italic> sites (i.e., attB-x<sup>smeg</sup>) label is coordinated with homologous sites in <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> (i.e., attB-x<sup>Mab</sup>) shown in panel B. The names of clusters or subclusters (or the phage name if it is a singleton) within which one or more phages use that site for integration are shown in large black type. “Y” or “S” superscripts on the cluster names denote whether the site is used by tyrosine- (Y) or serine (S) -integrases. <italic toggle="yes">attB</italic> sites for which integration-proficient vectors have been developed are indicated with a red asterisk. (<bold>B</bold>) <italic toggle="yes">attB</italic> sites in the <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> ATCC19977 genome mapped by identification of integrated prophages. The font color of the <italic toggle="yes">attB</italic> sites (i.e., attB-x<sup>Mab</sup>) is coordinated with their homologues in <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> (i.e., attB-x<sup>smeg</sup>) shown in panel A. Genome coordinates are shown in red type; genes are shown in blue type. The clusters/subclusters of prophages for which members are found integrated in those sites are shown in black type. “Y” or “S” superscripts on the cluster names denote whether the site is used by tyrosine- (Y) or serine (S) -integrases. The integration vectors based on phage L5 (attB-1<sup>smeg</sup>) integrate at a homologous site in <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> (shown in box) although no prophages have been identified there. This and the attB-7<sup>Mab</sup> site are only ones for which integration vectors have been shown to work (marked with red asterisks), but several vectors developed for <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> are predicted to also work in <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> (blue asterisks).</p>
        </caption>
        <graphic xlink:href="ppat.1010602.g004" position="float"/>
      </fig>
      <p>Interestingly, although <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> genomes are devoid of full-length prophages, prophages are abundant and diverse in <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> genomes [<xref rid="ppat.1010602.ref051" ref-type="bibr">51</xref>,<xref rid="ppat.1010602.ref066" ref-type="bibr">66</xref>], and the <italic toggle="yes">attB</italic> sites can be easily determined (<xref rid="ppat.1010602.g004" ref-type="fig">Fig 4B</xref>). Of the 21 <italic toggle="yes">attB</italic> sites, 16 are used by Int-Y and 5 by Int-S (<xref rid="ppat.1010602.g004" ref-type="fig">Fig 4B</xref>). Interestingly, of the 16 Int-Y <italic toggle="yes">attB</italic> sites, only 12 overlap a host tRNA gene and 4 are either within reading frames or in regulatory sequences. Eight of the <italic toggle="yes">attB</italic> sites used by Int-Y are conserved between <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> and <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> (<xref rid="ppat.1010602.g004" ref-type="fig">Fig 4</xref>). Ten of the <italic toggle="yes">attB</italic> sites identified in <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> are also present in <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> H37Rv [<xref rid="ppat.1010602.ref067" ref-type="bibr">67</xref>].</p>
    </sec>
    <sec id="sec010">
      <title>Host range</title>
      <p>The bacterium-phage billion-year-old battle for supremacy has profoundly influenced microbial evolution, sharply honed the variation among bacterial and phage strains, and molded the specificity of phages for their hosts. The expectation is thus that phages isolated on one host may infect other hosts, but that there will be substantial variations in host range. Furthermore, host range is malleable, and if an appropriate nonpermissive strain is tested, host range mutants (HRMs) of the phage can be readily isolated that either expand or switch the phage preferences [<xref rid="ppat.1010602.ref068" ref-type="bibr">68</xref>].</p>
      <p>Currently, our understanding of the host range of mycobacteriophages is at low resolution, with relatively few <italic toggle="yes">Mycobacterium</italic> strains tested [<xref rid="ppat.1010602.ref068" ref-type="bibr">68</xref>–<xref rid="ppat.1010602.ref070" ref-type="bibr">70</xref>]. There is a great deal more to be learned by expanding the scale of experimental analyses, and determination of the phage preferences for hundreds of <italic toggle="yes">Mycobacterium</italic> species and strains. However, important insights have been gleaned by determining the phage infection profiles on <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> strains, <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> clinical isolates, and other <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> strains [<xref rid="ppat.1010602.ref068" ref-type="bibr">68</xref>,<xref rid="ppat.1010602.ref070" ref-type="bibr">70</xref>,<xref rid="ppat.1010602.ref071" ref-type="bibr">71</xref>]. A notable finding is that there is a close correlation between the ability of phages to infect both <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> mc<sup>2</sup>155 and <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> H37Rv and their cluster/subcluster/singleton designation [<xref rid="ppat.1010602.ref068" ref-type="bibr">68</xref>]. The correlation is imperfect in that not all phages within a cluster/subcluster necessarily infect both strains, but there are many groups for which none of the phages infect both strains. Interestingly, a phage isolated in the 1960s (DS6A) only infects strains in the <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> complex [<xref rid="ppat.1010602.ref072" ref-type="bibr">72</xref>].</p>
      <p>Early host range studies with <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> used the common H37Rv lab strain [<xref rid="ppat.1010602.ref068" ref-type="bibr">68</xref>]. In general, phages isolated on <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> that efficiently infect <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> H37Rv also infect other <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> strains [<xref rid="ppat.1010602.ref071" ref-type="bibr">71</xref>]. There are some exceptions though, and phage Muddy efficiently infects only about one-third of the <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> reference strains tested [<xref rid="ppat.1010602.ref071" ref-type="bibr">71</xref>]. However, HRMs of Muddy can be isolated on the “nonpermissive” strains with a single amino acid substitution in the putative tail spike protein that not only efficiently infect the strain from which it was recovered, but also all <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> (lineage 1 to 4) strains [<xref rid="ppat.1010602.ref071" ref-type="bibr">71</xref>]. Interestingly, phage BPs does not efficiently infect <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> H37Rv, but HRMs can be readily isolated that do, and these also have substitutions in a putative tail spike protein [<xref rid="ppat.1010602.ref042" ref-type="bibr">42</xref>,<xref rid="ppat.1010602.ref068" ref-type="bibr">68</xref>]. However, none of the HRMs tested infect any of the other <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> reference strains [<xref rid="ppat.1010602.ref071" ref-type="bibr">71</xref>]. Presumably, different HRMs could be isolated on other nonpermissive <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> isolates.</p>
      <p><italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> clinical isolates are at the opposite end of the spectrum to <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> in their variation in phage infection profiles [<xref rid="ppat.1010602.ref070" ref-type="bibr">70</xref>]. In general, <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> isolates have either smooth or rough colony morphotypes, with the smooth strains having abundant surface GPLs; relatively few of the <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> phages infect and kill any of the smooth isolates [<xref rid="ppat.1010602.ref070" ref-type="bibr">70</xref>]. The phages that infect <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> rough colony strains are generally within clusters/subclusters that also infect <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> [<xref rid="ppat.1010602.ref070" ref-type="bibr">70</xref>]. However, there is great variation among <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> clinical isolates in their phage infection profiles, even among those that overall are very closely related genetically [<xref rid="ppat.1010602.ref070" ref-type="bibr">70</xref>]. It would thus be misleading to test just a single isolate of <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> and assume that its phage infection profile was representative of all isolates.</p>
      <p>What determines phage host range? There are a multitude of players, but they can be generally grouped into those acting at the cell surface (e.g., receptors) and those that act after the DNA has entered the cell (e.g., restriction). Interestingly, many <italic toggle="yes">Mycobacterium</italic> strains—including <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic>—are CRISPR-free that eliminates a major potential contributor to host range, but they likely have a variety of restriction–modification (R–M) systems [<xref rid="ppat.1010602.ref073" ref-type="bibr">73</xref>–<xref rid="ppat.1010602.ref076" ref-type="bibr">76</xref>]. They may also vary in their surface structures that are recognized as receptors by the phages, although few phage receptors in <italic toggle="yes">Mycobacterium</italic> strains have been described. Curiously, GPLs are implicated as potential receptors for phage I3 infection of <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic>, and yet their abundance in smooth <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> strains is implicated in reduced phage infection [<xref rid="ppat.1010602.ref077" ref-type="bibr">77</xref>]. As noted above, several phage HRMs have been described with altered tail spike proteins and these presumably alter receptor recognition by the phages, even though the receptors are not well defined. But some HRMs map in other genes including in portal proteins likely responding to defense mechanisms operating at post-injection phage growth [<xref rid="ppat.1010602.ref078" ref-type="bibr">78</xref>].</p>
    </sec>
    <sec id="sec011">
      <title>Prophage-mediated viral defense systems</title>
      <p>Interestingly, prophages can be a major source of phage defense systems [<xref rid="ppat.1010602.ref057" ref-type="bibr">57</xref>,<xref rid="ppat.1010602.ref079" ref-type="bibr">79</xref>,<xref rid="ppat.1010602.ref080" ref-type="bibr">80</xref>]. It is no surprise that lysogens are immune to superinfection by the same (and closely related) phages (i.e., homotypic defense), and the mechanisms of repressor-mediated immunity have been long studied. However, prophages can play more complex roles by expressing genes that influence the infection of other, unrelated phages (i.e., heterotypic defense) [<xref rid="ppat.1010602.ref079" ref-type="bibr">79</xref>,<xref rid="ppat.1010602.ref081" ref-type="bibr">81</xref>]. In some instances, these heterotypic defenses can be very specific for one or only a small number of superinfecting phages, while having no effect on genetic siblings or cousins of those phages. Because <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> genomes are so richly endowed with prophages (see <xref rid="ppat.1010602.g004" ref-type="fig">Fig 4B</xref>), these are prime candidates for influencing the highly varied phage infection profiles [<xref rid="ppat.1010602.ref051" ref-type="bibr">51</xref>].</p>
      <p>Many different prophage-mediated defense systems have been described, some of which likely act by influencing adsorption or DNA injection for the superinfecting phage, and others that prevent phage infection through abortive infection systems. One group of phages prominently implicated in these systems are the Cluster N mycobacteriophages, which are genomically diverse in a central portion of the genomes—adjacent to the immunity and integration region—and each phage has 3 to 9 genes that are expressed lysogenically [<xref rid="ppat.1010602.ref079" ref-type="bibr">79</xref>]. In one example, an <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> lysogen carrying a Charlie prophage expresses a protein, gp32, a predicted membrane protein, and defends against infection by phage Che9c (Cluster I1). Charlie gp32 not only impairs plaque formation but also lysogeny, and gp32 likely acts in an exclusion-like process, preventing DNA injection into the cytoplasm [<xref rid="ppat.1010602.ref079" ref-type="bibr">79</xref>]. Che9c is the only known phage to which Charlie gp32 provides defense. In a second example, phage Phrann codes for a putative (p)ppGpp synthetase (gp29) and gp30 which when expressed together from a prophage confer defense against several unrelated phages including phage Tweety [<xref rid="ppat.1010602.ref079" ref-type="bibr">79</xref>]. Expression of Phrann gp29/gp30 strongly inhibits Tweety plaque formation but not Tweety lysogeny. In this case, we propose that Tweety DNA injection results in activation of the (p)ppGpp synthetase, growth arrest, and abortive infection [<xref rid="ppat.1010602.ref079" ref-type="bibr">79</xref>].</p>
    </sec>
    <sec id="sec012">
      <title>A counterdefense system in mycobacteriophage Tweety</title>
      <p>Interestingly, Tweety encodes for an intriguing counterdefense system, which is not active against the Phrann gp29/gp30 system but is activatable or “tunable” mutationally [<xref rid="ppat.1010602.ref079" ref-type="bibr">79</xref>]. Specifically, Tweety defense escape mutants (DEMs) can be readily isolated that overcome the defense (i.e., form plaques efficiently on a strain expressing Phrann gp29/gp30) and have mutations that map in Tweety gene <italic toggle="yes">54</italic> (<xref rid="ppat.1010602.g001" ref-type="fig">Fig 1</xref>). Tweety gene <italic toggle="yes">54</italic> is unusual in that it codes for a gp54 protein with unique C- and N-terminal regions flanking 40 to 48 copies of a tetrapeptide repeat of which the first 2 amino acids are alanine [<xref rid="ppat.1010602.ref079" ref-type="bibr">79</xref>]. The DEMs vary by the number of these tetrapeptide repeats—either more or fewer—suggesting that specific juxtaposition of the C- and N-terminal “domains” are required for it to be tuned to inactivate the Phrann gp29/gp30 system. We propose a model in which Phrann gp29 normally binds to gp30 to prevent enzymatic activity, and that activation of the system occurs by dissociation of gp29 and gp30 in response to some—as yet unknown—aspect of Tweety infection [<xref rid="ppat.1010602.ref079" ref-type="bibr">79</xref>]. However, if Tweety gp54 is tuned to Phrann gp29/gp30 (as in the DEMs), Tweety gp54 may lock in the Phrann gp29/gp30 complex, prevent dissociation, and thus prevent defense.</p>
    </sec>
    <sec id="sec013">
      <title>Mycobacteriophage genes toxic to bacterial growth</title>
      <p>It is likely that phage genes play important roles not just in host range determination, but in other aspects of viral dynamics, including out-competing other phages in lytic growth. Several studies have shown that a substantial proportion (approximately 20%) of phage genes are toxic to the host cell when expressed alone [<xref rid="ppat.1010602.ref082" ref-type="bibr">82</xref>,<xref rid="ppat.1010602.ref083" ref-type="bibr">83</xref>]. This toxicity itself is likely immaterial to lytic phage growth, as the cell is going to die anyway, and we suggest it more commonly derives from inactivation of cell processes that other phages depend on to lytically infect the bacterium. Thus, a phage undergoing lytic growth can prevent viral “gate-crashers” by shutting down systems that the interlopers are dependent on. One example is Fruitloop gp52, a small (93 amino acids) protein expressed in phage Fruitloop early lytic growth that interacts directly with the host DivIVA protein and inactivates it [<xref rid="ppat.1010602.ref082" ref-type="bibr">82</xref>]. An unrelated phage, Rosebush, requires DivIVA to infect, and is therefore excluded from Fruitloop-infected cells by this mechanism [<xref rid="ppat.1010602.ref082" ref-type="bibr">82</xref>]. It seems likely that other genes identified as toxic are involved in similar processes [<xref rid="ppat.1010602.ref083" ref-type="bibr">83</xref>].</p>
    </sec>
    <sec id="sec014">
      <title>Phage-based tools for <italic toggle="yes">Mycobacterium</italic> genetics</title>
      <p>Mycobacteriophages have facilitated development of several widely used tools for <italic toggle="yes">Mycobacterium</italic> genetics. The slow growth rate and pathogenicity confounded genetic manipulation of <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> for many years, and the need to exploit phage-based systems to overcome these obstacles was recognized early on by Jacobs and colleagues [<xref rid="ppat.1010602.ref084" ref-type="bibr">84</xref>]. The extant tools fall into 2 main groups: those that use phage derivatives to take advantage of efficient DNA injection and those that utilize phage genes for tool development. The first category includes phage-based systems for delivery of transposons, allelic exchange modules, and reporter genes and are useful for many <italic toggle="yes">Mycobacterium</italic> hosts, including <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic>, <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic>, and <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> [<xref rid="ppat.1010602.ref085" ref-type="bibr">85</xref>–<xref rid="ppat.1010602.ref092" ref-type="bibr">92</xref>]. An obvious advantage of these systems is that phages introduce DNA into bacterial cells at high frequencies, much greater than is typically achieved by transformation or conjugation. Thus, reporter genes can be introduced into clinical samples for rapid determination of drug susceptibilities [<xref rid="ppat.1010602.ref088" ref-type="bibr">88</xref>,<xref rid="ppat.1010602.ref089" ref-type="bibr">89</xref>,<xref rid="ppat.1010602.ref093" ref-type="bibr">93</xref>], transposons can be delivered for the construction of high-density mutant libraries [<xref rid="ppat.1010602.ref091" ref-type="bibr">91</xref>], and allelic exchange substrates can be delivered for constructing knockout mutants [<xref rid="ppat.1010602.ref085" ref-type="bibr">85</xref>,<xref rid="ppat.1010602.ref087" ref-type="bibr">87</xref>]. All of these approaches have been facilitated by the construction and manipulation of shuttle phasmids, which are chimeras that replicate as phages in <italic toggle="yes">Mycobacterium</italic>, and as large plasmids in <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> [<xref rid="ppat.1010602.ref084" ref-type="bibr">84</xref>,<xref rid="ppat.1010602.ref094" ref-type="bibr">94</xref>–<xref rid="ppat.1010602.ref096" ref-type="bibr">96</xref>].</p>
      <p>Phages have also been used for generalized transduction, as described for phage I3 [<xref rid="ppat.1010602.ref097" ref-type="bibr">97</xref>,<xref rid="ppat.1010602.ref098" ref-type="bibr">98</xref>], and subsequently for Bxz1 [<xref rid="ppat.1010602.ref099" ref-type="bibr">99</xref>] (both in Cluster C), although primarily in <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic>. Interestingly, all of the phages known to infect <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> have <italic toggle="yes">cos</italic>-packaging systems and are unlikely to mediate generalized transduction. A generalized transducing phage for <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> thus remains a desirable but as yet unachieved goal.</p>
      <p>Secondly, several generally applicable tools have been developed from mycobacteriophage genomes. Integration-proficient plasmid vectors have found wide usage, as they facilitate the construction of single-copy recombinants in a wide variety of strains. They simply contain a plasmid vector backbone, a selectable marker, and the integrase gene and <italic toggle="yes">attP</italic> site from a mycobacteriophage; typically, they exclude the phage-encoded RDF, which otherwise would promote plasmid excision. The first such vector was derived from phage L5, which integrates into the <italic toggle="yes">attB</italic>-L5 site (attB-1<sup>smeg</sup>), a short (approximately 40 bp) sequence overlapping a host tRNA<sup>gly</sup> gene (<xref rid="ppat.1010602.g003" ref-type="fig">Fig 3</xref>). Transformation with an L5 integration vector is efficient, the host tRNA is “reconstructed” following integration, and recombinants generally are genetically stable [<xref rid="ppat.1010602.ref100" ref-type="bibr">100</xref>]; however, they will be lost in the absence of selection if recombinant gene impairs bacterial growth. Excision can be facilitated if desired by introduction of the phage RDF gene [<xref rid="ppat.1010602.ref101" ref-type="bibr">101</xref>]. Integration vectors have been described using at least 6 different <italic toggle="yes">attB</italic> sites, including from phages Bxb1 [<xref rid="ppat.1010602.ref064" ref-type="bibr">64</xref>], Tweety [<xref rid="ppat.1010602.ref032" ref-type="bibr">32</xref>], and Giles [<xref rid="ppat.1010602.ref102" ref-type="bibr">102</xref>] (<xref rid="ppat.1010602.g004" ref-type="fig">Fig 4A</xref>); a multitude of additional vectors could be constructed to expand the suite of useful and compatible plasmids. Because many of the <italic toggle="yes">attB</italic> sites are conserved between <italic toggle="yes">Mycobacterium</italic> species, most of the vectors can be used in both <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> and <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic>, as well as <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> (<xref rid="ppat.1010602.g004" ref-type="fig">Fig 4</xref>). The vectors can also be used with selectable markers based on phage immunity genes rather than antibiotic resistance, using lytic versions of the phages to select for transformants [<xref rid="ppat.1010602.ref047" ref-type="bibr">47</xref>,<xref rid="ppat.1010602.ref052" ref-type="bibr">52</xref>].</p>
      <p>Recombineering systems are also widely used for <italic toggle="yes">Mycobacterium</italic> genetics [<xref rid="ppat.1010602.ref103" ref-type="bibr">103</xref>–<xref rid="ppat.1010602.ref106" ref-type="bibr">106</xref>]. These mimic the recombineering systems developed from phage lambda and related systems for <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> [<xref rid="ppat.1010602.ref107" ref-type="bibr">107</xref>,<xref rid="ppat.1010602.ref108" ref-type="bibr">108</xref>], which do not work efficiently in <italic toggle="yes">Mycobacterium</italic> strains. Plasmids for <italic toggle="yes">Mycobacterium</italic> recombineering use mycobacteriophage-derived recombinases, most notably from phage Che9c [<xref rid="ppat.1010602.ref103" ref-type="bibr">103</xref>–<xref rid="ppat.1010602.ref106" ref-type="bibr">106</xref>]. Strains can be readily constructed that express Che9c genes <italic toggle="yes">60</italic> and <italic toggle="yes">61</italic>, encoding an exonuclease and a DNA-pairing protein, respectively, that promote recombination of dsDNA substrates introduced by electroporation [<xref rid="ppat.1010602.ref103" ref-type="bibr">103</xref>]. These can be used for constructing gene knockouts and other mutants in both slow- and fast-growing <italic toggle="yes">Mycobacterium</italic> strains. Alternatively, single-stranded DNA (ssDNA) recombineering can be achieved using oligonucleotides, which requires only the DNA-pairing protein (Che9c gp60) [<xref rid="ppat.1010602.ref104" ref-type="bibr">104</xref>]. Several important adaptations of these systems are noteworthy, including the ORBIT system that combines ssDNA recombineering with the Bxb1 integration system [<xref rid="ppat.1010602.ref109" ref-type="bibr">109</xref>], and its application for the engineering of the phages themselves [<xref rid="ppat.1010602.ref110" ref-type="bibr">110</xref>]. This latter system, dubbed Bacteriophage Recombineering of Electroporated DNA (BRED) is a useful approach for constructing phage mutants and recombinants [<xref rid="ppat.1010602.ref110" ref-type="bibr">110</xref>–<xref rid="ppat.1010602.ref112" ref-type="bibr">112</xref>], which can be made more efficient by coupling with CRISPR-mediated counterselection in the CRISPY-BRED configuration [<xref rid="ppat.1010602.ref113" ref-type="bibr">113</xref>].</p>
    </sec>
    <sec id="sec015">
      <title>Therapeutic applications of mycobacteriophages</title>
      <p>The potential therapeutic use of bacteriophages has been postulated for over 100 years, with numerous reports of successful use, especially in eastern Europe and the former Soviet Union [<xref rid="ppat.1010602.ref114" ref-type="bibr">114</xref>]. The notion of antimicrobial action by lytic phages is not surprising, especially for topical applications in which access to the pathogen is anticipated, but prospects for lung infections, skin diseases, and disseminated infections such as those caused by pathogenic <italic toggle="yes">Mycobacteria</italic> are much less certain. The first report of phages for treating a <italic toggle="yes">Mycobacterium</italic> infection was for a pediatric cystic fibrosis (CF) patient with a disseminated <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> infection following a bilateral lung transplant and immunosuppressive therapy to support the new lungs [<xref rid="ppat.1010602.ref078" ref-type="bibr">78</xref>]. Resolution of the infection was neither fast nor complete, but there was substantial improvement after about 6 weeks of treatment, with improvement in a large infected node in the liver, reduction in skin nodules, and closure of the sternal transplant wound [<xref rid="ppat.1010602.ref078" ref-type="bibr">78</xref>]. There are several important lessons from this case study. First, a considerable search was needed to identify phages that efficiently infect and kill the specific <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> isolate (designated GD01). Very few phages have been identified using any strain of <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> as a host for isolation, and de novo phage discovery using <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> GD01 was mostly unproductive [<xref rid="ppat.1010602.ref078" ref-type="bibr">78</xref>]. However, a screen of the large collection of <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> phages identified 2 that did, and a third was developed by isolating an HRM of phage BPs. Second, 2 of the 3 phages are temperate, which do not kill bacteria efficiently (see above), and it was necessary to construct lytic derivatives using BRED engineering to remove all or part of the repressor gene [<xref rid="ppat.1010602.ref056" ref-type="bibr">56</xref>,<xref rid="ppat.1010602.ref078" ref-type="bibr">78</xref>]. Third, the 3-phage cocktail was used with a view to avoid treatment failure due to the emergence of phage resistance. The cross-resistance profiles for the phages were not known, but the 3 phages are genomically distinct (from 3 different clusters), optimizing the prospects for using different infection mechanisms. Indeed, no resistance was observed in any post-treatment isolate. Fourth, the phages were administered intravenously twice daily (10<sup>9</sup> plaque forming units/dose) without severe adverse reactions. Fifth, no neutralizing antibody response to the phages was observed, although immunosuppressive drugs were being administered [<xref rid="ppat.1010602.ref078" ref-type="bibr">78</xref>].</p>
      <p>Broadening the use of phages for treating <italic toggle="yes">Mycobacterium</italic> infections must overcome several limitations. Perhaps most importantly, there is substantial variation in the phage infection profiles among clinical isolates of <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic>, and thus the phages useful in the first case are not generally useful for other infections [<xref rid="ppat.1010602.ref070" ref-type="bibr">70</xref>]. A screen of 82 clinical isolates illustrates this variation, and also shows that the repertoire of potentially therapeutically useful phages is quite limited (6 to 8) [<xref rid="ppat.1010602.ref070" ref-type="bibr">70</xref>]. Moreover, these isolates can be categorized as having either smooth or rough colony morphotypes, and relatively few phages infect and kill any of the smooth strains efficiently. Thus, identifying therapeutically useful phages for <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> smooth strains is a key priority. Even among rough strains, the phage infection profiles vary considerably among closely related strains [<xref rid="ppat.1010602.ref070" ref-type="bibr">70</xref>], and the plasmids and prophages are likely major contributors to the phage infection profiles [<xref rid="ppat.1010602.ref051" ref-type="bibr">51</xref>]. About 75% of the rough strains are infected and killed by one or more phages and expanding the repertoire of therapeutically useful phages is also a high priority. Using a broader variety of <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> isolates for de novo phage isolation may be helpful, as well as exploring the utility of phages isolated on alternative <italic toggle="yes">Mycobacterium</italic> strains. Because <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> genomes are replete with diverse prophages [<xref rid="ppat.1010602.ref051" ref-type="bibr">51</xref>], these may be a good source new phages, following spontaneous induction, growth on a permissive host, and engineering to be obligatorily lytic [<xref rid="ppat.1010602.ref070" ref-type="bibr">70</xref>].</p>
      <p>Screening of over 200 <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> clinical isolates facilitated therapeutic interventions in at least 20 additional compassionate use cases of highly drug resistant <italic toggle="yes">Mycobacterium</italic> strains [<xref rid="ppat.1010602.ref115" ref-type="bibr">115</xref>]. These revealed a further set of key insights. First, favorable clinical or microbiological outcomes were observed in at least 11 of these cases and are incomplete or inconclusive in 5 others. However, little or no change in clinical outcomes were observed in 4 cases. All of these are confounded by complex circumstances involving other infections and clinical conditions; in any one case the linkage between phage administration and clinical outcome may seem compelling, but the roles of other factors cannot be excluded. For 1 CF patient, phage administration over the course of a year was associated with conversion to sputum culture negative, re-listing for lung transplantation, and an eventual bilateral lung transplant [<xref rid="ppat.1010602.ref116" ref-type="bibr">116</xref>]. In another patient, a highly refractory severe <italic toggle="yes">M</italic>. <italic toggle="yes">chelonae</italic> skin infection was resolved after IV administration without any other changes in antibiotic treatment [<xref rid="ppat.1010602.ref117" ref-type="bibr">117</xref>]. Interestingly, phage resistance leading to treatment failure was not observed in any of these cases, even though 11 were treated with only a single phage. Although it is premature of conclude that phage resistance is not an impediment to therapy of <italic toggle="yes">Mycobacterium</italic> infections, it may be less of a concern than for some other bacterial pathogens. Finally, emergence of a neutralizing antibody response to the phages was not uncommon. In one case, this correlated with loss of sustained clinical improvement [<xref rid="ppat.1010602.ref118" ref-type="bibr">118</xref>,<xref rid="ppat.1010602.ref119" ref-type="bibr">119</xref>], but in others, it does not appear to have interrupted clinical improvement. Overall, these compassionate use interventions provide helpful findings for constructing robust clinical trials aimed at elucidating safety, efficacy, dosage, routes of administration, and pharmacokinetics.</p>
      <p>Several other <italic toggle="yes">Mycobacterium</italic> diseases might be targets for therapeutic phage treatments including Buruli ulcers caused by <italic toggle="yes">M</italic>. <italic toggle="yes">ulcerans</italic> infections [<xref rid="ppat.1010602.ref069" ref-type="bibr">69</xref>,<xref rid="ppat.1010602.ref120" ref-type="bibr">120</xref>] and tuberculosis caused by <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> [<xref rid="ppat.1010602.ref071" ref-type="bibr">71</xref>,<xref rid="ppat.1010602.ref121" ref-type="bibr">121</xref>–<xref rid="ppat.1010602.ref124" ref-type="bibr">124</xref>]. Tuberculosis remains an interesting target but presents a different set of challenges than <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> infections. Importantly, there is much more limited strain variation in the phage infection profiles, reflecting the lack of plasmids and prophages in <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic> clinical isolates, such that a small cocktail of phages should be useful for a wide variety of clinical isolates [<xref rid="ppat.1010602.ref071" ref-type="bibr">71</xref>]. However, gaining phage access to intracellular bacteria may be a challenge requiring modified delivery systems such as liposomes or “Trojan horse” strategies [<xref rid="ppat.1010602.ref125" ref-type="bibr">125</xref>–<xref rid="ppat.1010602.ref127" ref-type="bibr">127</xref>], although phage virions can be phagocytosed by macrophages, and transcytosis has been demonstrated [<xref rid="ppat.1010602.ref128" ref-type="bibr">128</xref>,<xref rid="ppat.1010602.ref129" ref-type="bibr">129</xref>]. However, there could be potential benefits to improving disease and limiting transmission by killing extracellular bacteria, in conjunction with ongoing antibiotic treatments [<xref rid="ppat.1010602.ref123" ref-type="bibr">123</xref>]. The prevalence of highly drug resistant strains of <italic toggle="yes">M</italic>. <italic toggle="yes">tuberculosis</italic>, and the threat of resistance to newly developed anti-TB drugs warrants continued investigation into possible roles for phages in controlling this important human disease.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec016">
    <title>Conclusions</title>
    <p>Our understanding of mycobacteriophages has expanded enormously since they were first described over 70 years ago. However, there is still so much more to learn. We have a high-resolution view of the genomics of phages that infect <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic>, but there are hundreds of other <italic toggle="yes">Mycobacterium</italic> species and strains that could be used to discover entirely new sets of phages unrelated to these. We note for example, that most <italic toggle="yes">M</italic>. <italic toggle="yes">abscessus</italic> prophages are unrelated to <italic toggle="yes">M</italic>. <italic toggle="yes">smegmatis</italic> phages, and their diversity is at least as great [<xref rid="ppat.1010602.ref051" ref-type="bibr">51</xref>]. Preliminary analyses suggest that this is also true for prophages of other <italic toggle="yes">Mycobacterium</italic> strains. We also lack any detailed understanding of the host receptors used for specific recognition by the phages, or more generally what determines host range. It seems likely that there are a multitude of systems contributing to this, including both core bacterial functions and those provided by prophages and plasmids. There are additional genetic tools that could be developed from the phages including in vivo and in vitro packaging systems, vector systems including those using plasmidial prophage origins of replication [<xref rid="ppat.1010602.ref045" ref-type="bibr">45</xref>], and phage-based vaccine systems [<xref rid="ppat.1010602.ref130" ref-type="bibr">130</xref>]. The therapeutic potential of mycobacteriophages is also in its infancy, and it remains to be seen whether they will prove useful only as treatments of last resort, or whether they are more generally useful. Overall, mycobacteriophages have a rich and promising future.</p>
  </sec>
</body>
<back>
  <ack>
    <p>Much of the work described here was performed in my lab over an extended period of time and I’d like to thank the many superb researchers who have contributed. I would also like to thank the multitude of faculty and students in the PHIRE and SEA-PHAGES programs who isolated and characterized the phages, as well as all my terrific colleagues for many exciting collaborations. I thank my lab colleagues for comments on the manuscript, especially Krista Freeman, Carlos Guerrero, Debbie Jacobs-Sera, and Katie Wetzel.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ppat.1010602.ref001">
      <label>1</label>
      <mixed-citation publication-type="book"><name><surname>Rohwer</surname><given-names>F</given-names></name>, <name><surname>Youle</surname><given-names>M</given-names></name>, <name><surname>Maughan</surname><given-names>H</given-names></name>, <name><surname>Hisakawa</surname><given-names>N</given-names></name>. <source>Life in our phage world: A centenial field guide to the earth’s most diverse inhiabitants</source>. <publisher-loc>San Diego, CA</publisher-loc>: <publisher-name>Wholon</publisher-name>; <year>2014</year>.</mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Mushegian</surname><given-names>AR</given-names></name>. <article-title>Are There 10(31) Virus Particles on Earth, or More, or Fewer?</article-title><source>J Bacteriol</source>. <year>2020</year>;<volume>202</volume>(<issue>9</issue>). Epub 2020/02/20. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JB.00052-20</pub-id> ; PubMed Central PMCID: PMC7148134.<?supplied-pmid 32071093?><pub-id pub-id-type="pmid">32071093</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Hendrix</surname><given-names>RW</given-names></name>, <name><surname>Smith</surname><given-names>MC</given-names></name>, <name><surname>Burns</surname><given-names>RN</given-names></name>, <name><surname>Ford</surname><given-names>ME</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Evolutionary relationships among diverse bacteriophages and prophages: all the world’s a phage</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1999</year>;<volume>96</volume>(<issue>5</issue>):<fpage>2192</fpage>–<lpage>7</lpage>. Epub 1999/03/03. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.96.5.2192</pub-id> ; PubMed Central PMCID: PMC26759.<?supplied-pmid 10051617?><pub-id pub-id-type="pmid">10051617</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Hendrix</surname><given-names>RW</given-names></name>. <article-title>Bacteriophages: evolution of the majority</article-title>. <source>Theor Popul Biol</source>. <year>2002</year>;<volume>61</volume> (<issue>4</issue>):<fpage>471</fpage>–<lpage>80</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1006/tpbi.2002.1590</pub-id> .<?supplied-pmid 12167366?><pub-id pub-id-type="pmid">12167366</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Hatfull</surname><given-names>GF</given-names></name>, <name><surname>Hendrix</surname><given-names>RW</given-names></name>. <article-title>Bacteriophages and their Genomes.</article-title><source>Curr Opin Virol</source>. <year>2011</year>;<volume>1</volume>:<fpage>298</fpage>–<lpage>303</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.coviro.2011.06.009</pub-id><?supplied-pmid 22034588?><pub-id pub-id-type="pmid">22034588</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Bernheim</surname><given-names>A</given-names></name>, <name><surname>Sorek</surname><given-names>R</given-names></name>. <article-title>The pan-immune system of bacteria: antiviral defence as a community resource</article-title>. <source>Nat Rev Microbiol</source>. <year>2020</year>;<volume>18</volume>(<issue>2</issue>):<fpage>113</fpage>–<lpage>9</lpage>. Epub 2019/11/07. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41579-019-0278-2</pub-id> .<?supplied-pmid 31695182?><pub-id pub-id-type="pmid">31695182</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>Pawluk</surname><given-names>A</given-names></name>, <name><surname>Davidson</surname><given-names>AR</given-names></name>, <name><surname>Maxwell</surname><given-names>KL</given-names></name>. <article-title>Anti-CRISPR: discovery, mechanism and function</article-title>. <source>Nat Rev Microbiol</source>. <year>2018</year>;<volume>16</volume>(<issue>1</issue>):<fpage>12</fpage>–<lpage>7</lpage>. Epub 2017/10/25. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrmicro.2017.120</pub-id> .<?supplied-pmid 29062071?><pub-id pub-id-type="pmid">29062071</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref008">
      <label>8</label>
      <mixed-citation publication-type="book"><name><surname>Hendrix</surname><given-names>RW</given-names></name>, <name><surname>Bamford</surname><given-names>D</given-names></name>, <name><surname>Casjens</surname><given-names>S</given-names></name>, <name><surname>Christie</surname><given-names>G</given-names></name>, <name><surname>Duda</surname><given-names>B</given-names></name>, <name><surname>Grimes</surname><given-names>SN</given-names></name>, <etal>et al</etal>. <source>Bacteriophages. Fields Virology</source>. <edition designator="6">6th ed</edition>. (Vol. 1). <publisher-name>Wolters Kluwer Health Adis (ESP)</publisher-name>; <year>2013</year>.</mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Ackermann</surname><given-names>HW</given-names></name>. <article-title>5500 Phages examined in the electron microscope</article-title>. <source>Arch Virol</source>. <year>2007</year>;<volume>152</volume>(<issue>2</issue>):<fpage>227</fpage>–<lpage>43</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00705-006-0849-1</pub-id> .<?supplied-pmid 17051420?><pub-id pub-id-type="pmid">17051420</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Russell</surname><given-names>DA</given-names></name>. <article-title>Sequencing, Assembling, and Finishing Complete Bacteriophage Genomes</article-title>. <source>Methods Mol Biol</source>. <year>2018</year>;<volume>1681</volume>:<fpage>109</fpage>–<lpage>25</lpage>. Epub 2017/11/15. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/978-1-4939-7343-9_9</pub-id> .<?supplied-pmid 29134591?><pub-id pub-id-type="pmid">29134591</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Dyson</surname><given-names>ZA</given-names></name>, <name><surname>Tucci</surname><given-names>J</given-names></name>, <name><surname>Seviour</surname><given-names>RJ</given-names></name>, <name><surname>Petrovski</surname><given-names>S</given-names></name>. <article-title>Lysis to Kill: Evaluation of the Lytic Abilities, and Genomics of Nine Bacteriophages Infective for Gordonia spp. and Their Potential Use in Activated Sludge Foam Biocontrol.</article-title><source>PLoS ONE</source>. <year>2015</year>;<volume>10</volume>(<issue>8</issue>):<fpage>e0134512</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0134512</pub-id> ; PubMed Central PMCID: PMC4524720.<?supplied-pmid 26241321?><pub-id pub-id-type="pmid">26241321</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Petrovski</surname><given-names>S</given-names></name>, <name><surname>Seviour</surname><given-names>RJ</given-names></name>, <name><surname>Tillett</surname><given-names>D</given-names></name>. <article-title>Characterization of the genome of the polyvalent lytic bacteriophage GTE2, which has potential for biocontrol of Gordonia-, Rhodococcus-, and Nocardia-stabilized foams in activated sludge plants</article-title>. <source>Appl Environ Microbiol</source>. <year>2011</year>;<volume>77</volume>(<issue>12</issue>):<fpage>3923</fpage>–<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/AEM.00025-11</pub-id> ; PubMed Central PMCID: PMC3131622.<?supplied-pmid 21498753?><pub-id pub-id-type="pmid">21498753</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Gauthier</surname><given-names>CH</given-names></name>, <name><surname>Abad</surname><given-names>L</given-names></name>, <name><surname>Venbakkam</surname><given-names>AK</given-names></name>, <name><surname>Malnak</surname><given-names>J</given-names></name>, <name><surname>Russell</surname><given-names>DA</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>DEPhT: a novel approach for efficient prophage discovery and precise extraction</article-title>. <source>Nucleic Acids Res</source>. <year>2022</year>. Epub 2022/04/23. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/gkac273</pub-id><?supplied-pmid 35451479?><pub-id pub-id-type="pmid">35451479</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Secor</surname><given-names>PR</given-names></name>, <name><surname>Burgener</surname><given-names>EB</given-names></name>, <name><surname>Kinnersley</surname><given-names>M</given-names></name>, <name><surname>Jennings</surname><given-names>LK</given-names></name>, <name><surname>Roman-Cruz</surname><given-names>V</given-names></name>, <name><surname>Popescu</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections.</article-title><source>Front Immunol.</source><year>2020</year>;<volume>11</volume>:<fpage>244</fpage>. Epub 2020/03/11. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fimmu.2020.00244</pub-id> ; PubMed Central PMCID: PMC7047154.<?supplied-pmid 32153575?><pub-id pub-id-type="pmid">32153575</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>Engel</surname><given-names>HW</given-names></name>. <article-title>Mycobacteriophages and phage typing.</article-title><source>Ann Microbiol (Paris).</source><year>1978</year>;<volume>129</volume> (<issue>1</issue>):<fpage>75</fpage>–<lpage>90</lpage>. <?supplied-pmid 418716?><pub-id pub-id-type="pmid">418716</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Uchiyama</surname><given-names>J</given-names></name>, <name><surname>Mizukami</surname><given-names>K</given-names></name>, <name><surname>Yahara</surname><given-names>K</given-names></name>, <name><surname>Kato</surname><given-names>SI</given-names></name>, <name><surname>Murakami</surname><given-names>H</given-names></name>, <name><surname>Nasukawa</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Genome Sequences of 12 Mycobacteriophages Recovered from Archival Stocks in Japan.</article-title><source>Genome Announc.</source><year>2018</year>;<volume>6</volume>(<issue>25</issue>). Epub 2018/06/23. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/genomeA.00472-18</pub-id> ; PubMed Central PMCID: PMC6013612.<?supplied-pmid 29930032?><pub-id pub-id-type="pmid">29930032</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>Ujihara</surname><given-names>T</given-names></name>, <name><surname>Uchiyama</surname><given-names>J</given-names></name>, <name><surname>Nasukawa</surname><given-names>T</given-names></name>, <name><surname>Ando</surname><given-names>H</given-names></name>, <name><surname>Murakami</surname><given-names>H</given-names></name>, <name><surname>Ohara</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Recovery of mycobacteriophages from archival stocks stored for approximately 50 years in Japan.</article-title><source>Arch Virol</source>. <year>2018</year>;<volume>163</volume>(<issue>7</issue>):<fpage>1915</fpage>–<lpage>9</lpage>. Epub 2018/03/08. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00705-018-3788-8</pub-id> .<?supplied-pmid 29511830?><pub-id pub-id-type="pmid">29511830</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref018">
      <label>18</label>
      <mixed-citation publication-type="journal"><name><surname>Hatfull</surname><given-names>GF</given-names></name>, <name><surname>Sarkis</surname><given-names>GJ</given-names></name>. <article-title>DNA sequence, structure and gene expression of mycobacteriophage L5: a phage system for mycobacterial genetics.</article-title><source>Mol Microbiol.</source><year>1993</year>;<volume>7</volume>(<issue>3</issue>):<fpage>395</fpage>–<lpage>405</lpage>. Epub 1993/02/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2958.1993.tb01131.x</pub-id> .<?supplied-pmid 8459766?><pub-id pub-id-type="pmid">8459766</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref019">
      <label>19</label>
      <mixed-citation publication-type="journal"><name><surname>Doke</surname><given-names>S.</given-names></name><article-title>Studies on mycobacteriophages and lysogenic mycobacteria.</article-title><source>J Kumamoto Med Soc</source>. <year>1960</year>;<volume>34</volume>:<fpage>1360</fpage>–<lpage>73</lpage>.</mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref020">
      <label>20</label>
      <mixed-citation publication-type="journal"><name><surname>Ford</surname><given-names>ME</given-names></name>, <name><surname>Sarkis</surname><given-names>GJ</given-names></name>, <name><surname>Belanger</surname><given-names>AE</given-names></name>, <name><surname>Hendrix</surname><given-names>RW</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Genome structure of mycobacteriophage D29: implications for phage evolution</article-title>. <source>J Mol Biol</source>. <year>1998</year>;<volume>279</volume>(<issue>1</issue>):<fpage>143</fpage>–<lpage>64</lpage>. Epub 1998/06/24. S0022-2836(97)91610-7 [pii] <comment>doi: </comment><pub-id pub-id-type="doi">10.1006/jmbi.1997.1610</pub-id> .<?supplied-pmid 9636706?><pub-id pub-id-type="pmid">9636706</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Ford</surname><given-names>ME</given-names></name>, <name><surname>Stenstrom</surname><given-names>C</given-names></name>, <name><surname>Hendrix</surname><given-names>RW</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Mycobacteriophage TM4: genome structure and gene expression</article-title>. <source>Tuber Lung Dis</source>. <year>1998</year>;<volume>79</volume>(<issue>2</issue>):<fpage>63</fpage>–<lpage>73</lpage>. Epub 2000/01/25. <comment>doi: </comment><pub-id pub-id-type="doi">10.1054/tuld.1998.0007</pub-id> S0962-8479(98)90007-7 [pii]. .<?supplied-pmid 10645443?><pub-id pub-id-type="pmid">10645443</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>Mediavilla</surname><given-names>J</given-names></name>, <name><surname>Jain</surname><given-names>S</given-names></name>, <name><surname>Kriakov</surname><given-names>J</given-names></name>, <name><surname>Ford</surname><given-names>ME</given-names></name>, <name><surname>Duda</surname><given-names>RL</given-names></name>, <name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <etal>et al</etal>. <article-title>Genome organization and characterization of mycobacteriophage Bxb1</article-title>. <source>Mol Microbiol</source>. <year>2000</year>;<volume>38</volume>(<issue>5</issue>):<fpage>955</fpage>–<lpage>70</lpage>. Epub 2000/12/21. mmi2183 [pii]. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.02183.x</pub-id> .<?supplied-pmid 11123671?><pub-id pub-id-type="pmid">11123671</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Pedulla</surname><given-names>ML</given-names></name>, <name><surname>Ford</surname><given-names>ME</given-names></name>, <name><surname>Houtz</surname><given-names>JM</given-names></name>, <name><surname>Karthikeyan</surname><given-names>T</given-names></name>, <name><surname>Wadsworth</surname><given-names>C</given-names></name>, <name><surname>Lewis</surname><given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Origins of highly mosaic mycobacteriophage genomes</article-title>. <source>Cell</source>. <year>2003</year>;<volume>113</volume>(<issue>2</issue>):<fpage>171</fpage>–<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0092-8674(03)00233-2</pub-id> .<?supplied-pmid 12705866?><pub-id pub-id-type="pmid">12705866</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref024">
      <label>24</label>
      <mixed-citation publication-type="book"><name><surname>Hatfull</surname><given-names>GF</given-names></name>. <source>Molecular Genetics of Mycobacteriophages</source>. In: <name><surname>Hatfull</surname><given-names>GF</given-names></name>, <name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, editors. <part-title>Molecular Genetics of the Mycobacteria.</part-title><publisher-loc>Washington, DC</publisher-loc>: <publisher-name>ASM Press</publisher-name>; <year>2000</year>. p. <fpage>37</fpage>–<lpage>54</lpage>.</mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref025">
      <label>25</label>
      <mixed-citation publication-type="journal"><name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Wildy Prize Lecture, 2020–2021: Who wouldn’t want to discover a new virus?</article-title><source>Microbiology (Reading).</source><year>2021</year>;<volume>167</volume>(<issue>9</issue>). Epub 2021/09/02. <comment>doi: </comment><pub-id pub-id-type="doi">10.1099/mic.0.001094</pub-id> .<?supplied-pmid 34468308?><pub-id pub-id-type="pmid">34468308</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref026">
      <label>26</label>
      <mixed-citation publication-type="journal"><name><surname>Hatfull</surname><given-names>GF</given-names></name>, <name><surname>Racaniello</surname><given-names>V</given-names></name>. <article-title>PHIRE and TWiV: Experiences in Bringing Virology to New Audiences.</article-title><source>Annu Rev Virol</source>. <year>2014</year>;<volume>1</volume>:<fpage>37</fpage>–<lpage>53</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev-virology-031413-085449</pub-id><?supplied-pmid 26958714?><pub-id pub-id-type="pmid">26958714</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref027">
      <label>27</label>
      <mixed-citation publication-type="journal"><name><surname>Hanauer</surname><given-names>DI</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Pedulla</surname><given-names>ML</given-names></name>, <name><surname>Cresawn</surname><given-names>SG</given-names></name>, <name><surname>Hendrix</surname><given-names>RW</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Inquiry learning. Teaching scientific inquiry</article-title>. <source>Science</source>. <year>2006</year>;<volume>314</volume>(<issue>5807</issue>):<fpage>1880</fpage>–<lpage>1</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.1136796</pub-id> .<?supplied-pmid 17185586?><pub-id pub-id-type="pmid">17185586</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref028">
      <label>28</label>
      <mixed-citation publication-type="journal"><name><surname>Jordan</surname><given-names>TC</given-names></name>, <name><surname>Burnett</surname><given-names>SH</given-names></name>, <name><surname>Carson</surname><given-names>S</given-names></name>, <name><surname>Caruso</surname><given-names>SM</given-names></name>, <name><surname>Clase</surname><given-names>K</given-names></name>, <name><surname>DeJong</surname><given-names>RJ</given-names></name>, <etal>et al</etal>. <article-title>A broadly implementable research course in phage discovery and genomics for first-year undergraduate students</article-title>. <source>MBio</source>. <year>2014</year>;<volume>5</volume>(<issue>1</issue>):<fpage>e01051</fpage>–<lpage>13</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.01051-13</pub-id> .<?supplied-pmid 24496795?><pub-id pub-id-type="pmid">24496795</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref029">
      <label>29</label>
      <mixed-citation publication-type="journal"><name><surname>Hanauer</surname><given-names>DI</given-names></name>, <name><surname>Graham</surname><given-names>MJ</given-names></name>, <name><surname>Sea</surname><given-names>P</given-names></name>, <name><surname>Betancur</surname><given-names>L</given-names></name>, <name><surname>Bobrownicki</surname><given-names>A</given-names></name>, <name><surname>Cresawn</surname><given-names>SG</given-names></name>, <etal>et al</etal>. <article-title>An inclusive Research Education Community (iREC): Impact of the SEA-PHAGES program on research outcomes and student learning.</article-title><source>Proc Natl Acad Sci U S A</source>. <year>2017</year>;<volume>114</volume>(<issue>51</issue>):<fpage>13531</fpage>–<lpage>6</lpage>. Epub 2017/12/07. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.1718188115</pub-id> ; PubMed Central PMCID: PMC5754813.<?supplied-pmid 29208718?><pub-id pub-id-type="pmid">29208718</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref030">
      <label>30</label>
      <mixed-citation publication-type="journal"><name><surname>Hanauer</surname><given-names>DI</given-names></name>, <name><surname>Graham</surname><given-names>MJ</given-names></name>, <name><surname>Arnold</surname><given-names>RJ</given-names></name>, <name><surname>Ayuk</surname><given-names>MA</given-names></name>, <name><surname>Balish</surname><given-names>MF</given-names></name>, <name><surname>Beyer</surname><given-names>AR</given-names></name>, <etal>et al</etal>. <article-title>Instructional Models for Course-Based Research Experience (CRE) Teaching.</article-title><source>CBE Life Sci Educ</source>. <year>2022</year>;<volume>21</volume>(<issue>1</issue>):<fpage>ar8</fpage>. Epub 2022/01/04. <comment>doi: </comment><pub-id pub-id-type="doi">10.1187/cbe.21-03-0057</pub-id> .<?supplied-pmid 34978921?><pub-id pub-id-type="pmid">34978921</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref031">
      <label>31</label>
      <mixed-citation publication-type="journal"><name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Actinobacteriophages: Genomics, Dynamics, and Applications.</article-title><source>Annu Rev Virol.</source><year>2020</year>;<volume>7</volume>(<issue>1</issue>):<fpage>37</fpage>–<lpage>61</lpage>. Epub 2020/09/30. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev-virology-122019-070009</pub-id> .<?supplied-pmid 32991269?><pub-id pub-id-type="pmid">32991269</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref032">
      <label>32</label>
      <mixed-citation publication-type="journal"><name><surname>Pham</surname><given-names>TT</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Pedulla</surname><given-names>ML</given-names></name>, <name><surname>Hendrix</surname><given-names>RW</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Comparative genomic analysis of mycobacteriophage Tweety: evolutionary insights and construction of compatible site-specific integration vectors for mycobacteria</article-title>. <source>Microbiology</source>. <year>2007</year>;<volume>153</volume>(<issue>Pt 8</issue>):<fpage>2711</fpage>–<lpage>23</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1099/mic.0.2007/008904-0</pub-id> .<?supplied-pmid 17660435?><pub-id pub-id-type="pmid">17660435</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref033">
      <label>33</label>
      <mixed-citation publication-type="journal"><name><surname>Hatfull</surname><given-names>GF</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Lawrence</surname><given-names>JG</given-names></name>, <name><surname>Pope</surname><given-names>WH</given-names></name>, <name><surname>Russell</surname><given-names>DA</given-names></name>, <name><surname>Ko</surname><given-names>CC</given-names></name>, <etal>et al</etal>. <article-title>Comparative Genomic Analysis of 60 Mycobacteriophage Genomes: Genome Clustering, Gene Acquisition, and Gene Size</article-title>. <source>J Mol Biol</source>. <year>2010</year>;<volume>397</volume>(<issue>1</issue>):<fpage>119</fpage>–<lpage>43</lpage>. Epub 2010/01/13. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jmb.2010.01.011</pub-id> .<?supplied-pmid 20064525?><pub-id pub-id-type="pmid">20064525</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref034">
      <label>34</label>
      <mixed-citation publication-type="journal"><name><surname>Hatfull</surname><given-names>GF</given-names></name>, <name><surname>Pedulla</surname><given-names>ML</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Cichon</surname><given-names>PM</given-names></name>, <name><surname>Foley</surname><given-names>A</given-names></name>, <name><surname>Ford</surname><given-names>ME</given-names></name>, <etal>et al</etal>. <article-title>Exploring the mycobacteriophage metaproteome: phage genomics as an educational platform</article-title>. <source>PLoS Genet</source>. <year>2006</year>;<volume>2</volume>(<issue>6</issue>):<fpage>e92</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pgen.0020092</pub-id> .<?supplied-pmid 16789831?><pub-id pub-id-type="pmid">16789831</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref035">
      <label>35</label>
      <mixed-citation publication-type="journal"><name><surname>Pope</surname><given-names>WH</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Russell</surname><given-names>DA</given-names></name>, <name><surname>Peebles</surname><given-names>CL</given-names></name>, <name><surname>Al-Atrache</surname><given-names>Z</given-names></name>, <name><surname>Alcoser</surname><given-names>TA</given-names></name>, <etal>et al</etal>. <article-title>Expanding the Diversity of Mycobacteriophages: Insights into Genome Architecture and Evolution.</article-title><source>PLoS ONE</source>. <year>2011</year>;<volume>6</volume>(<issue>1</issue>):<fpage>e16329</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0016329</pub-id><?supplied-pmid 21298013?><pub-id pub-id-type="pmid">21298013</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref036">
      <label>36</label>
      <mixed-citation publication-type="journal"><name><surname>Pope</surname><given-names>WH</given-names></name>, <name><surname>Bowman</surname><given-names>CA</given-names></name>, <name><surname>Russell</surname><given-names>DA</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Asai</surname><given-names>DJ</given-names></name>, <name><surname>Cresawn</surname><given-names>SG</given-names></name>, <etal>et al</etal>. <article-title>Whole genome comparison of a large collection of mycobacteriophages reveals a continuum of phage genetic diversity</article-title>. <source>Elife</source>. <year>2015</year>;<volume>4</volume>:<fpage>e06416</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.7554/eLife.06416</pub-id> ; PubMed Central PMCID: PMC4408529.<?supplied-pmid 25919952?><pub-id pub-id-type="pmid">25919952</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref037">
      <label>37</label>
      <mixed-citation publication-type="journal"><name><surname>Pope</surname><given-names>WH</given-names></name>, <name><surname>Mavrich</surname><given-names>TN</given-names></name>, <name><surname>Garlena</surname><given-names>RA</given-names></name>, <name><surname>Guerrero-Bustamante</surname><given-names>CA</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Montgomery</surname><given-names>MT</given-names></name>, <etal>et al</etal>. <article-title>Bacteriophages of Gordonia spp. Display a Spectrum of Diversity and Genetic Relationships</article-title>. <source>mBio</source>. <year>2017</year>;<volume>8</volume>(<issue>4</issue>). Epub 2017/08/16. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.01069-17</pub-id> ; PubMed Central PMCID: PMCPMC5559632<?supplied-pmid 28811342?><pub-id pub-id-type="pmid">28811342</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref038">
      <label>38</label>
      <mixed-citation publication-type="journal"><name><surname>Cresawn</surname><given-names>SG</given-names></name>, <name><surname>Bogel</surname><given-names>M</given-names></name>, <name><surname>Day</surname><given-names>N</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Hendrix</surname><given-names>RW</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Phamerator: a bioinformatic tool for comparative bacteriophage genomics</article-title>. <source>BMC Bioinformatics</source>. <year>2011</year>;<volume>12</volume>:<fpage>395</fpage>. Epub 2011/10/14. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2105-12-395</pub-id> ; PubMed Central PMCID: PMC3233612.<?supplied-pmid 21991981?><pub-id pub-id-type="pmid">21991981</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref039">
      <label>39</label>
      <mixed-citation publication-type="journal"><name><surname>Huson</surname><given-names>DH</given-names></name>. <article-title>SplitsTree: analyzing and visualizing evolutionary data</article-title>. <source>Bioinformatics</source>. <year>1998</year>;<volume>14</volume>(<issue>1</issue>):<fpage>68</fpage>–<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/bioinformatics/14.1.68</pub-id> .<?supplied-pmid 9520503?><pub-id pub-id-type="pmid">9520503</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref040">
      <label>40</label>
      <mixed-citation publication-type="journal"><name><surname>Mageeney</surname><given-names>C</given-names></name>, <name><surname>Pope</surname><given-names>WH</given-names></name>, <name><surname>Harrison</surname><given-names>M</given-names></name>, <name><surname>Moran</surname><given-names>D</given-names></name>, <name><surname>Cross</surname><given-names>T</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Mycobacteriophage Marvin: a new singleton phage with an unusual genome organization</article-title>. <source>J Virol</source>. <year>2012</year>;<volume>86</volume>(<issue>9</issue>):<fpage>4762</fpage>–<lpage>75</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JVI.00075-12</pub-id> ; PubMed Central PMCID: PMC3347389.<?supplied-pmid 22357284?><pub-id pub-id-type="pmid">22357284</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref041">
      <label>41</label>
      <mixed-citation publication-type="journal"><name><surname>Kelley</surname><given-names>DS</given-names></name>, <name><surname>Lennon</surname><given-names>CW</given-names></name>, <name><surname>Sea</surname><given-names>P</given-names></name>, <name><surname>Belfort</surname><given-names>M</given-names></name>, <name><surname>Novikova</surname><given-names>O</given-names></name>. <article-title>Mycobacteriophages as Incubators for Intein Dissemination and Evolution.</article-title><source>MBio</source>. <year>2016</year>;<volume>7</volume>(<issue>5</issue>). <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.01537-16</pub-id> ; PubMed Central PMCID: PMC5050341.<?supplied-pmid 27703073?><pub-id pub-id-type="pmid">27703073</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref042">
      <label>42</label>
      <mixed-citation publication-type="journal"><name><surname>Sampson</surname><given-names>T</given-names></name>, <name><surname>Broussard</surname><given-names>GW</given-names></name>, <name><surname>Marinelli</surname><given-names>LJ</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Ray</surname><given-names>M</given-names></name>, <name><surname>Ko</surname><given-names>CC</given-names></name>, <etal>et al</etal>. <article-title>Mycobacteriophages BPs, Angel and Halo: comparative genomics reveals a novel class of ultra-small mobile genetic elements</article-title>. <source>Microbiology</source>. <year>2009</year>;<volume>155</volume>(<issue>Pt 9</issue>):<fpage>2962</fpage>–<lpage>77</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1099/mic.0.030486-0</pub-id> .<?supplied-pmid 19556295?><pub-id pub-id-type="pmid">19556295</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref043">
      <label>43</label>
      <mixed-citation publication-type="journal"><name><surname>Martinsohn</surname><given-names>JT</given-names></name>, <name><surname>Radman</surname><given-names>M</given-names></name>, <name><surname>Petit</surname><given-names>MA</given-names></name>. <article-title>The lambda red proteins promote efficient recombination between diverged sequences: implications for bacteriophage genome mosaicism</article-title>. <source>PLoS Genet</source>. <year>2008</year>;<volume>4</volume>(<issue>5</issue>):<fpage>e1000065</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pgen.1000065</pub-id> .<?supplied-pmid 18451987?><pub-id pub-id-type="pmid">18451987</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref044">
      <label>44</label>
      <mixed-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Mavrich</surname><given-names>TN</given-names></name>, <name><surname>Ng</surname><given-names>WL</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Expression and evolutionary patterns of mycobacteriophage D29 and its temperate close relatives</article-title>. <source>BMC Microbiol</source>. <year>2017</year>;<volume>17</volume>(<issue>1</issue>):<fpage>225</fpage>. Epub 2017/12/05. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12866-017-1131-2</pub-id> ; PubMed Central PMCID: PMC5712189.<?supplied-pmid 29197343?><pub-id pub-id-type="pmid">29197343</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref045">
      <label>45</label>
      <mixed-citation publication-type="journal"><name><surname>Wetzel</surname><given-names>KS</given-names></name>, <name><surname>Aull</surname><given-names>HG</given-names></name>, <name><surname>Zack</surname><given-names>KM</given-names></name>, <name><surname>Garlena</surname><given-names>RA</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Protein-Mediated and RNA-Based Origins of Replication of Extrachromosomal Mycobacterial Prophages.</article-title><source>MBio</source>. <year>2020</year>;<volume>11</volume>(<issue>2</issue>). Epub 2020/03/27. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.00385-20</pub-id> ; PubMed Central PMCID: PMC7157519.<?supplied-pmid 32209683?><pub-id pub-id-type="pmid">32209683</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref046">
      <label>46</label>
      <mixed-citation publication-type="journal"><name><surname>Broussard</surname><given-names>GW</given-names></name>, <name><surname>Oldfield</surname><given-names>LM</given-names></name>, <name><surname>Villanueva</surname><given-names>VM</given-names></name>, <name><surname>Lunt</surname><given-names>BL</given-names></name>, <name><surname>Shine</surname><given-names>EE</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Integration-dependent bacteriophage immunity provides insights into the evolution of genetic switches</article-title>. <source>Mol Cell</source>. <year>2013</year>;<volume>49</volume>(<issue>2</issue>):<fpage>237</fpage>–<lpage>48</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.molcel.2012.11.012</pub-id> ; PubMed Central PMCID: PMC3557535.<?supplied-pmid 23246436?><pub-id pub-id-type="pmid">23246436</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref047">
      <label>47</label>
      <mixed-citation publication-type="journal"><name><surname>Petrova</surname><given-names>ZO</given-names></name>, <name><surname>Broussard</surname><given-names>GW</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Mycobacteriophage-repressor-mediated immunity as a selectable genetic marker: Adephagia and BPs repressor selection</article-title>. <source>Microbiology</source>. <year>2015</year>;<volume>161</volume>(<issue>8</issue>):<fpage>1539</fpage>–<lpage>51</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1099/mic.0.000120</pub-id> ; PubMed Central PMCID: PMC4681040.<?supplied-pmid 26066798?><pub-id pub-id-type="pmid">26066798</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref048">
      <label>48</label>
      <mixed-citation publication-type="journal"><name><surname>Court</surname><given-names>DL</given-names></name>, <name><surname>Oppenheim</surname><given-names>AB</given-names></name>, <name><surname>Adhya</surname><given-names>SL</given-names></name>. <article-title>A new look at bacteriophage lambda genetic networks</article-title>. <source>J Bacteriol</source>. <year>2007</year>;<volume>189</volume>(<issue>2</issue>):<fpage>298</fpage>–<lpage>304</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JB.01215-06</pub-id> .<?supplied-pmid 17085553?><pub-id pub-id-type="pmid">17085553</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref049">
      <label>49</label>
      <mixed-citation publication-type="journal"><name><surname>Little</surname><given-names>JW</given-names></name>. <article-title>Evolution of complex gene regulatory circuits by addition of refinements</article-title>. <source>Curr Biol</source>. <year>2010</year>;<volume>20</volume>(<issue>17</issue>):<fpage>R724</fpage>–<lpage>34</lpage>. Epub 2010/09/14. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cub.2010.06.028</pub-id> .<?supplied-pmid 20833317?><pub-id pub-id-type="pmid">20833317</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref050">
      <label>50</label>
      <mixed-citation publication-type="journal"><name><surname>Lewis</surname><given-names>JA</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Control of directionality in integrase-mediated recombination: examination of recombination directionality factors (RDFs) including Xis and Cox proteins.</article-title><source>Nucleic Acids Res</source>. <year>2001</year>;<volume>29</volume>(<issue>11</issue>):<fpage>2205</fpage>–<lpage>16</lpage>. Epub 2001/05/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/29.11.2205</pub-id> ; PubMed Central PMCID: PMC55702.<?supplied-pmid 11376138?><pub-id pub-id-type="pmid">11376138</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref051">
      <label>51</label>
      <mixed-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Aull</surname><given-names>HG</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Garlena</surname><given-names>RA</given-names></name>, <name><surname>Russell</surname><given-names>DA</given-names></name>, <name><surname>Smith</surname><given-names>BE</given-names></name>, <etal>et al</etal>. <article-title>The Prophage and Plasmid Mobilome as a Likely Driver of Mycobacterium abscessus Diversity.</article-title><source>MBio</source>. <year>2021</year>;<volume>12</volume>(<issue>2</issue>). Epub 2021/04/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.03441-20</pub-id> ; PubMed Central PMCID: PMC8092301.<?supplied-pmid 33785627?><pub-id pub-id-type="pmid">33785627</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref052">
      <label>52</label>
      <mixed-citation publication-type="journal"><name><surname>Donnelly-Wu</surname><given-names>MK</given-names></name>, <name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria</article-title>. <source>Mol Microbiol</source>. <year>1993</year>;<volume>7</volume>(<issue>3</issue>):<fpage>407</fpage>–<lpage>17</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2958.1993.tb01132.x</pub-id> .<?supplied-pmid 8459767?><pub-id pub-id-type="pmid">8459767</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref053">
      <label>53</label>
      <mixed-citation publication-type="journal"><name><surname>Jain</surname><given-names>S</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Transcriptional regulation and immunity in mycobacteriophage Bxb1</article-title>. <source>Mol Microbiol</source>. <year>2000</year>;<volume>38</volume>(<issue>5</issue>):<fpage>971</fpage>–<lpage>85</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.02184.x</pub-id> .<?supplied-pmid 11123672?><pub-id pub-id-type="pmid">11123672</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref054">
      <label>54</label>
      <mixed-citation publication-type="journal"><name><surname>Mavrich</surname><given-names>TN</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Evolution of Superinfection Immunity in Cluster A Mycobacteriophages.</article-title><source>MBio</source>. <year>2019</year>;<volume>10</volume>(<issue>3</issue>). Epub 2019/06/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.00971-19</pub-id> ; PubMed Central PMCID: PMC6550527.<?supplied-pmid 31164468?><pub-id pub-id-type="pmid">31164468</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref055">
      <label>55</label>
      <mixed-citation publication-type="journal"><name><surname>Brown</surname><given-names>KL</given-names></name>, <name><surname>Sarkis</surname><given-names>GJ</given-names></name>, <name><surname>Wadsworth</surname><given-names>C</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Transcriptional silencing by the mycobacteriophage L5 repressor</article-title>. <source>EMBO J</source>. <year>1997</year>;<volume>16</volume>(<issue>19</issue>):<fpage>5914</fpage>–<lpage>21</lpage>. Epub 1997/10/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/emboj/16.19.5914</pub-id> PubMed Central PMCID: PMC1170222. <?supplied-pmid 9312049?><pub-id pub-id-type="pmid">9312049</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref056">
      <label>56</label>
      <mixed-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Guerrero Bustamante</surname><given-names>CA</given-names></name>, <name><surname>Garlena</surname><given-names>RA</given-names></name>, <name><surname>Pinches</surname><given-names>RS</given-names></name>, <name><surname>Cornely</surname><given-names>K</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Mycobacteriophage ZoeJ: A broad host-range close relative of mycobacteriophage TM4</article-title>. <source>Tuberculosis (Edinb).</source><year>2019</year>;<volume>115</volume>:<fpage>14</fpage>–<lpage>23</lpage>. Epub 2019/04/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.tube.2019.01.002</pub-id> ; PubMed Central PMCID: PMC6452893.<?supplied-pmid 30948168?><pub-id pub-id-type="pmid">30948168</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref057">
      <label>57</label>
      <mixed-citation publication-type="journal"><name><surname>Gentile</surname><given-names>GM</given-names></name>, <name><surname>Wetzel</surname><given-names>KS</given-names></name>, <name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Montgomery</surname><given-names>MT</given-names></name>, <name><surname>Garlena</surname><given-names>RA</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>More Evidence of Collusion: a New Prophage-Mediated Viral Defense System Encoded by Mycobacteriophage Sbash.</article-title><source>MBio</source>. <year>2019</year>;<volume>10</volume>(<issue>2</issue>). Epub 2019/03/21. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.00196-19</pub-id> .<?supplied-pmid 30890613?><pub-id pub-id-type="pmid">30890613</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref058">
      <label>58</label>
      <mixed-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Marinelli</surname><given-names>LJ</given-names></name>, <name><surname>Newton</surname><given-names>GL</given-names></name>, <name><surname>Pogliano</surname><given-names>K</given-names></name>, <name><surname>Pogliano</surname><given-names>J</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Functional requirements for bacteriophage growth: gene essentiality and expression in mycobacteriophage Giles</article-title>. <source>Mol Microbiol</source>. <year>2013</year>;<volume>88</volume>(<issue>3</issue>):<fpage>577</fpage>–<lpage>89</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/mmi.12210</pub-id> ; PubMed Central PMCID: PMC3641587.<?supplied-pmid 23560716?><pub-id pub-id-type="pmid">23560716</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref059">
      <label>59</label>
      <mixed-citation publication-type="journal"><name><surname>Nesbit</surname><given-names>CE</given-names></name>, <name><surname>Levin</surname><given-names>ME</given-names></name>, <name><surname>Donnelly-Wu</surname><given-names>MK</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Transcriptional regulation of repressor synthesis in mycobacteriophage L5</article-title>. <source>Mol Microbiol</source>. <year>1995</year>;<volume>17</volume>(<issue>6</issue>):<fpage>1045</fpage>–<lpage>56</lpage>. Epub 1995/09/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2958.1995.mmi_17061045.x</pub-id> .<?supplied-pmid 8594325?><pub-id pub-id-type="pmid">8594325</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref060">
      <label>60</label>
      <mixed-citation publication-type="journal"><name><surname>Ghosh</surname><given-names>P</given-names></name>, <name><surname>Kim</surname><given-names>AI</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>The orientation of mycobacteriophage Bxb1 integration is solely dependent on the central dinucleotide of attP and attB</article-title>. <source>Mol Cell</source>. <year>2003</year>;<volume>12</volume>(<issue>5</issue>):<fpage>1101</fpage>–<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s1097-2765(03)00444-1</pub-id> .<?supplied-pmid 14636570?><pub-id pub-id-type="pmid">14636570</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref061">
      <label>61</label>
      <mixed-citation publication-type="journal"><name><surname>Singh</surname><given-names>S</given-names></name>, <name><surname>Rockenbach</surname><given-names>K</given-names></name>, <name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Vandemark</surname><given-names>AP</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Cross-talk between Diverse Serine Integrases</article-title>. <source>J Mol Biol</source>. <year>2014</year>;<volume>426</volume>(<issue>2</issue>):<fpage>318</fpage>–<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jmb.2013.10.013</pub-id> .<?supplied-pmid 24161951?><pub-id pub-id-type="pmid">24161951</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref062">
      <label>62</label>
      <mixed-citation publication-type="journal"><name><surname>Bibb</surname><given-names>LA</given-names></name>, <name><surname>Hancox</surname><given-names>MI</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Integration and excision by the large serine recombinase phiRv1 integrase</article-title>. <source>Mol Microbiol</source>. <year>2005</year>;<volume>55</volume>(<issue>6</issue>):<fpage>1896</fpage>–<lpage>910</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04517.x</pub-id> .<?supplied-pmid 15752208?><pub-id pub-id-type="pmid">15752208</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref063">
      <label>63</label>
      <mixed-citation publication-type="journal"><name><surname>Bibb</surname><given-names>LA</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Integration and excision of the Mycobacterium tuberculosis prophage-like element, phiRv1</article-title>. <source>Mol Microbiol</source>. <year>2002</year>;<volume>45</volume>(<issue>6</issue>):<fpage>1515</fpage>–<lpage>26</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03130.x</pub-id> .<?supplied-pmid 12354222?><pub-id pub-id-type="pmid">12354222</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref064">
      <label>64</label>
      <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>AI</given-names></name>, <name><surname>Ghosh</surname><given-names>P</given-names></name>, <name><surname>Aaron</surname><given-names>MA</given-names></name>, <name><surname>Bibb</surname><given-names>LA</given-names></name>, <name><surname>Jain</surname><given-names>S</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Mycobacteriophage Bxb1 integrates into the Mycobacterium smegmatis groEL1 gene</article-title>. <source>Mol Microbiol</source>. <year>2003</year>;<volume>50</volume>(<issue>2</issue>):<fpage>463</fpage>–<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03723.x</pub-id> .<?supplied-pmid 14617171?><pub-id pub-id-type="pmid">14617171</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref065">
      <label>65</label>
      <mixed-citation publication-type="journal"><name><surname>Ojha</surname><given-names>A</given-names></name>, <name><surname>Anand</surname><given-names>M</given-names></name>, <name><surname>Bhatt</surname><given-names>A</given-names></name>, <name><surname>Kremer</surname><given-names>L</given-names></name>, <name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria</article-title>. <source>Cell</source>. <year>2005</year>;<volume>123</volume>(<issue>5</issue>):<fpage>861</fpage>–<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2005.09.012</pub-id> .<?supplied-pmid 16325580?><pub-id pub-id-type="pmid">16325580</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref066">
      <label>66</label>
      <mixed-citation publication-type="journal"><name><surname>Glickman</surname><given-names>C</given-names></name>, <name><surname>Kammlade</surname><given-names>SM</given-names></name>, <name><surname>Hasan</surname><given-names>NA</given-names></name>, <name><surname>Epperson</surname><given-names>LE</given-names></name>, <name><surname>Davidson</surname><given-names>RM</given-names></name>, <name><surname>Strong</surname><given-names>M</given-names></name>. <article-title>Characterization of integrated prophages within diverse species of clinical nontuberculous mycobacteria.</article-title><source>Virol J.</source><year>2020</year>;<volume>17</volume>(<issue>1</issue>):<fpage>124</fpage>. Epub 2020/08/19. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12985-020-01394-y</pub-id> ; PubMed Central PMCID: PMC7433156.<?supplied-pmid 32807206?><pub-id pub-id-type="pmid">32807206</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref067">
      <label>67</label>
      <mixed-citation publication-type="journal"><name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>The secret lives of mycobacteriophages</article-title>. <source>Adv Virus Res</source>. <year>2012</year>;<volume>82</volume>:<fpage>179</fpage>–<lpage>288</lpage>. Epub 2012/03/17. B978-0-12-394621-8.00015–7 [pii] <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/B978-0-12-394621-8.00015-7</pub-id> .<?supplied-pmid 22420855?><pub-id pub-id-type="pmid">22420855</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref068">
      <label>68</label>
      <mixed-citation publication-type="journal"><name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Marinelli</surname><given-names>LJ</given-names></name>, <name><surname>Bowman</surname><given-names>C</given-names></name>, <name><surname>Broussard</surname><given-names>GW</given-names></name>, <name><surname>Guerrero Bustamante</surname><given-names>C</given-names></name>, <name><surname>Boyle</surname><given-names>MM</given-names></name>, <etal>et al</etal>. <article-title>On the nature of mycobacteriophage diversity and host preference</article-title>. <source>Virology</source>. <year>2012</year>;<volume>434</volume>(<issue>2</issue>):<fpage>187</fpage>–<lpage>201</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.virol.2012.09.026</pub-id> ; PubMed Central PMCID: PMC3518647.<?supplied-pmid 23084079?><pub-id pub-id-type="pmid">23084079</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref069">
      <label>69</label>
      <mixed-citation publication-type="journal"><name><surname>Rybniker</surname><given-names>J</given-names></name>, <name><surname>Kramme</surname><given-names>S</given-names></name>, <name><surname>Small</surname><given-names>PL</given-names></name>. <article-title>Host range of 14 mycobacteriophages in Mycobacterium ulcerans and seven other mycobacteria including Mycobacterium tuberculosis—application for identification and susceptibility testing</article-title>. <source>J Med Microbiol</source>. <year>2006</year>;<volume>55</volume>(<issue>Pt 1</issue>):<fpage>37</fpage>–<lpage>42</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1099/jmm.0.46238-0</pub-id> .<?supplied-pmid 16388028?><pub-id pub-id-type="pmid">16388028</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref070">
      <label>70</label>
      <mixed-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Smith</surname><given-names>BE</given-names></name>, <name><surname>Garlena</surname><given-names>RA</given-names></name>, <name><surname>Russell</surname><given-names>DA</given-names></name>, <name><surname>Aull</surname><given-names>HG</given-names></name>, <name><surname>Mahalingam</surname><given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance.</article-title><source>MBio</source>. <year>2021</year>;<volume>12</volume>(<issue>2</issue>). Epub 2021/04/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.03431-20</pub-id> ; PubMed Central PMCID: PMC8092298.<?supplied-pmid 33785625?><pub-id pub-id-type="pmid">33785625</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref071">
      <label>71</label>
      <mixed-citation publication-type="journal"><name><surname>Guerrero-Bustamante</surname><given-names>CA</given-names></name>, <name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Garlena</surname><given-names>RA</given-names></name>, <name><surname>Russell</surname><given-names>DA</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains.</article-title><source>MBio</source>. <year>2021</year>;<volume>12</volume>(<issue>3</issue>). Epub 2021/05/22. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.00973-21</pub-id> ; PubMed Central PMCID: PMC8263002.<?supplied-pmid 34016711?><pub-id pub-id-type="pmid">34016711</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref072">
      <label>72</label>
      <mixed-citation publication-type="journal"><name><surname>Redmond</surname><given-names>WB</given-names></name>, <name><surname>Carter</surname><given-names>JC</given-names></name>. <article-title>A bacteriophage specific to <italic toggle="yes">Mycobacterium tuberculosis</italic> varieties <italic toggle="yes">hominis</italic> and <italic toggle="yes">bovis</italic></article-title>. <source>Am Rv Respir Dis</source>. <year>1960</year>;<volume>82</volume>:<fpage>781</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1164/arrd.1960.82.6.781</pub-id><?supplied-pmid 13740230?><pub-id pub-id-type="pmid">13740230</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref073">
      <label>73</label>
      <mixed-citation publication-type="journal"><name><surname>Shankar</surname><given-names>S</given-names></name>, <name><surname>Tyagi</surname><given-names>AK</given-names></name>. <article-title>MhaAI, a novel isoschizomer of PstI from Mycobacterium habana recognizing 5’-CTGCA/G-3’.</article-title><source>Nucleic Acids Res</source>. <year>1992</year>;<volume>20</volume> (<issue>11</issue>):<fpage>2891</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/20.11.2891</pub-id>
<?supplied-pmid 1614878?><pub-id pub-id-type="pmid">1614878</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref074">
      <label>74</label>
      <mixed-citation publication-type="journal"><name><surname>Shankar</surname><given-names>S</given-names></name>, <name><surname>Tyagi</surname><given-names>AK</given-names></name>. <article-title>MfoAI, a novel isoschizomer of HaeIII from Mycobacterium fortuitum recognizing 5’-GG/CC-3’.</article-title><source>Nucleic Acids Res</source>. <year>1992</year>;<volume>20</volume>(<issue>11</issue>):<fpage>2890</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nar/20.11.2890</pub-id><?supplied-pmid 1614877?><pub-id pub-id-type="pmid">1614877</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref075">
      <label>75</label>
      <mixed-citation publication-type="journal"><name><surname>Shankar</surname><given-names>S</given-names></name>, <name><surname>Tyagi</surname><given-names>AK</given-names></name>. <article-title>MchAI and MchAII, two class-II restriction endonucleases from Mycobacterium chelonei</article-title>. <source>Gene</source>. <year>1993</year>;<volume>132</volume>(<issue>1</issue>):<fpage>119</fpage>–<lpage>23</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0378-1119(93)90523-6</pub-id><?supplied-pmid 8406034?><pub-id pub-id-type="pmid">8406034</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref076">
      <label>76</label>
      <mixed-citation publication-type="journal"><name><surname>Shankar</surname><given-names>S</given-names></name>, <name><surname>Tyagi</surname><given-names>AK</given-names></name>. <article-title>Purification and characterization of restriction endonuclease MgoI from Mycobacterium gordonae</article-title>. <source>Gene</source>. <year>1993</year>;<volume>131</volume> (<issue>1</issue>):<fpage>153</fpage>–<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0378-1119(93)90686-w</pub-id>
<?supplied-pmid 8370536?><pub-id pub-id-type="pmid">8370536</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref077">
      <label>77</label>
      <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Kriakov</surname><given-names>J</given-names></name>, <name><surname>Singh</surname><given-names>A</given-names></name>, <name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <name><surname>Besra</surname><given-names>GS</given-names></name>, <name><surname>Bhatt</surname><given-names>A</given-names></name>. <article-title>Defects in glycopeptidolipid biosynthesis confer phage I3 resistance in Mycobacterium smegmatis</article-title>. <source>Microbiology</source>. <year>2009</year>;<volume>155</volume>(<issue>Pt 12</issue>):<fpage>4050</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1099/mic.0.033209-0</pub-id> .<?supplied-pmid 19744987?><pub-id pub-id-type="pmid">19744987</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref078">
      <label>78</label>
      <mixed-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>R</given-names></name>, <name><surname>Guerrero Bustamante</surname><given-names>C</given-names></name>, <name><surname>Garlena</surname><given-names>RA</given-names></name>, <name><surname>Russell</surname><given-names>DA</given-names></name>, <name><surname>Ford</surname><given-names>K</given-names></name>, <name><surname>Harris</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant <italic toggle="yes">Mycobacterium abscessus</italic></article-title>. <source>Nat Med</source>. <year>2019</year>;<volume>25</volume>:<fpage>730</fpage>–<lpage>3</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41591-019-0437-z</pub-id><?supplied-pmid 31068712?><pub-id pub-id-type="pmid">31068712</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref079">
      <label>79</label>
      <mixed-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Bustamante</surname><given-names>CA</given-names></name>, <name><surname>Garlena</surname><given-names>RA</given-names></name>, <name><surname>Mavrich</surname><given-names>TN</given-names></name>, <name><surname>Pope</surname><given-names>WH</given-names></name>, <etal>et al</etal>. <article-title>Prophage-mediated defence against viral attack and viral counter-defence.</article-title><source>Nat Microbiol.</source><year>2017</year>;<volume>2</volume>:<fpage>16251</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.251</pub-id> ; PubMed Central PMCID: PMC5508108.<?supplied-pmid 28067906?><pub-id pub-id-type="pmid">28067906</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref080">
      <label>80</label>
      <mixed-citation publication-type="journal"><name><surname>Montgomery</surname><given-names>MT</given-names></name>, <name><surname>Guerrero Bustamante</surname><given-names>CA</given-names></name>, <name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Yet More Evidence of Collusion: a New Viral Defense System Encoded by Gordonia Phage CarolAnn.</article-title><source>MBio</source>. <year>2019</year>;<volume>10</volume>(<issue>2</issue>). Epub 2019/03/21. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.02417-18</pub-id> ; PubMed Central PMCID: PMC6426606.<?supplied-pmid 30890601?><pub-id pub-id-type="pmid">30890601</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref081">
      <label>81</label>
      <mixed-citation publication-type="journal"><name><surname>Bondy-Denomy</surname><given-names>J</given-names></name>, <name><surname>Qian</surname><given-names>J</given-names></name>, <name><surname>Westra</surname><given-names>ER</given-names></name>, <name><surname>Buckling</surname><given-names>A</given-names></name>, <name><surname>Guttman</surname><given-names>DS</given-names></name>, <name><surname>Davidson</surname><given-names>AR</given-names></name>, <etal>et al</etal>. <article-title>Prophages mediate defense against phage infection through diverse mechanisms.</article-title><source>ISME J.</source><year>2016</year>;<volume>10</volume>(<issue>12</issue>):<fpage>2854</fpage>–<lpage>66</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/ismej.2016.79</pub-id> ; PubMed Central PMCID: PMC5148200.<?supplied-pmid 27258950?><pub-id pub-id-type="pmid">27258950</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref082">
      <label>82</label>
      <mixed-citation publication-type="journal"><name><surname>Ko</surname><given-names>CC</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Mycobacteriophage Fruitloop gp52 inactivates Wag31 (DivIVA) to prevent heterotypic superinfection.</article-title><source>Mol Microbiol</source>. <year>2018</year>. Epub 2018/03/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/mmi.13946</pub-id> .<?supplied-pmid 29488662?><pub-id pub-id-type="pmid">29488662</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref083">
      <label>83</label>
      <mixed-citation publication-type="journal"><name><surname>Ko</surname><given-names>CC</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Identification of mycobacteriophage toxic genes reveals new features of mycobacterial physiology and morphology.</article-title><source>Sci Rep.</source><year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>14670</fpage>. Epub 2020/09/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-020-71588-5</pub-id> ; PubMed Central PMCID: PMC7474061.<?supplied-pmid 32887931?><pub-id pub-id-type="pmid">32887931</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref084">
      <label>84</label>
      <mixed-citation publication-type="journal"><name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <name><surname>Tuckman</surname><given-names>M</given-names></name>, <name><surname>Bloom</surname><given-names>BR</given-names></name>. <article-title>Introduction of foreign DNA into mycobacteria using a shuttle phasmid</article-title>. <source>Nature</source>. <year>1987</year>;<volume>327</volume>(<issue>6122</issue>):<fpage>532</fpage>–<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/327532a0</pub-id><?supplied-pmid 3473289?><pub-id pub-id-type="pmid">3473289</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref085">
      <label>85</label>
      <mixed-citation publication-type="journal"><name><surname>Bardarov</surname><given-names>S</given-names></name>, <name><surname>Bardarov</surname><given-names>S</given-names><suffix>Jr</suffix></name>, <name><surname>Pavelka</surname><given-names>MS</given-names></name>, <name><surname>Sambandamurthy</surname><given-names>V</given-names></name>, <name><surname>Larsen</surname><given-names>M</given-names></name>, <name><surname>Tufariello</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis.</article-title><source>Microbiology</source>. <year>2002</year>;<volume>148</volume>(<issue>Pt 10</issue>):<fpage>3007</fpage>–<lpage>17</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1099/00221287-148-10-3007</pub-id> .<?supplied-pmid 12368434?><pub-id pub-id-type="pmid">12368434</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref086">
      <label>86</label>
      <mixed-citation publication-type="journal"><name><surname>Jain</surname><given-names>P</given-names></name>, <name><surname>Hsu</surname><given-names>T</given-names></name>, <name><surname>Arai</surname><given-names>M</given-names></name>, <name><surname>Biermann</surname><given-names>K</given-names></name>, <name><surname>Thaler</surname><given-names>DS</given-names></name>, <name><surname>Nguyen</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Specialized transduction designed for precise high-throughput unmarked deletions in Mycobacterium tuberculosis</article-title>. <source>MBio</source>. <year>2014</year>;<volume>5</volume>(<issue>3</issue>):<fpage>e01245</fpage>–<lpage>14</lpage>. Epub 2014/06/05. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.01245-14</pub-id> ; PubMed Central PMCID: PMC4049104.<?supplied-pmid 24895308?><pub-id pub-id-type="pmid">24895308</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref087">
      <label>87</label>
      <mixed-citation publication-type="journal"><name><surname>Tufariello</surname><given-names>JM</given-names></name>, <name><surname>Malek</surname><given-names>AA</given-names></name>, <name><surname>Vilcheze</surname><given-names>C</given-names></name>, <name><surname>Cole</surname><given-names>LE</given-names></name>, <name><surname>Ratner</surname><given-names>HK</given-names></name>, <name><surname>Gonzalez</surname><given-names>PA</given-names></name>, <etal>et al</etal>. <article-title>Enhanced specialized transduction using recombineering in Mycobacterium tuberculosis</article-title>. <source>MBio</source>. <year>2014</year>;<volume>5</volume>(<issue>3</issue>):<fpage>e01179</fpage>–<lpage>14</lpage>. Epub 2014/05/29. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.01179-14</pub-id> ; PubMed Central PMCID: PMC4045075.<?supplied-pmid 24865558?><pub-id pub-id-type="pmid">24865558</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref088">
      <label>88</label>
      <mixed-citation publication-type="journal"><name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <name><surname>Barletta</surname><given-names>RG</given-names></name>, <name><surname>Udani</surname><given-names>R</given-names></name>, <name><surname>Chan</surname><given-names>J</given-names></name>, <name><surname>Kalkut</surname><given-names>G</given-names></name>, <name><surname>Sosne</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages</article-title>. <source>Science</source>. <year>1993</year>;<volume>260</volume>(<issue>5109</issue>):<fpage>819</fpage>–<lpage>22</lpage>. Epub 1993/05/07. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.8484123</pub-id> .<?supplied-pmid 8484123?><pub-id pub-id-type="pmid">8484123</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref089">
      <label>89</label>
      <mixed-citation publication-type="journal"><name><surname>Jain</surname><given-names>P</given-names></name>, <name><surname>Hartman</surname><given-names>TE</given-names></name>, <name><surname>Eisenberg</surname><given-names>N</given-names></name>, <name><surname>O’Donnell</surname><given-names>MR</given-names></name>, <name><surname>Kriakov</surname><given-names>J</given-names></name>, <name><surname>Govender</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>phi(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.</article-title><source>J Clin Microbiol</source>. <year>2012</year>;<volume>50</volume>(<issue>4</issue>):<fpage>1362</fpage>–<lpage>9</lpage>. Epub 2012/01/27. JCM.06192-11 [pii] <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.06192-11</pub-id> ; PubMed Central PMCID: PMC3318544.<?supplied-pmid 22278833?><pub-id pub-id-type="pmid">22278833</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref090">
      <label>90</label>
      <mixed-citation publication-type="journal"><name><surname>Piuri</surname><given-names>M</given-names></name>, <name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis</article-title>. <source>PLoS ONE</source>. <year>2009</year>;<volume>4</volume>(<issue>3</issue>):<fpage>e4870</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0004870</pub-id> .<?supplied-pmid 19300517?><pub-id pub-id-type="pmid">19300517</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref091">
      <label>91</label>
      <mixed-citation publication-type="journal"><name><surname>Bardarov</surname><given-names>S</given-names></name>, <name><surname>Kriakov</surname><given-names>J</given-names></name>, <name><surname>Carriere</surname><given-names>C</given-names></name>, <name><surname>Yu</surname><given-names>S</given-names></name>, <name><surname>Vaamonde</surname><given-names>C</given-names></name>, <name><surname>McAdam</surname><given-names>RA</given-names></name>, <etal>et al</etal>. <article-title>Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1997</year>;<volume>94</volume>(<issue>20</issue>):<fpage>10961</fpage>–<lpage>6</lpage>. Epub 1997/10/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.94.20.10961</pub-id> ; PubMed Central PMCID: PMC23545.<?supplied-pmid 9380742?><pub-id pub-id-type="pmid">9380742</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref092">
      <label>92</label>
      <mixed-citation publication-type="journal"><name><surname>Sassetti</surname><given-names>CM</given-names></name>, <name><surname>Boyd</surname><given-names>DH</given-names></name>, <name><surname>Rubin</surname><given-names>EJ</given-names></name>. <article-title>Genes required for mycobacterial growth defined by high density mutagenesis</article-title>. <source>Mol Microbiol</source>. <year>2003</year>;<volume>48</volume>(<issue>1</issue>):<fpage>77</fpage>–<lpage>84</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03425.x</pub-id> .<?supplied-pmid 12657046?><pub-id pub-id-type="pmid">12657046</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref093">
      <label>93</label>
      <mixed-citation publication-type="journal"><name><surname>O’Donnell</surname><given-names>MR</given-names></name>, <name><surname>Pym</surname><given-names>A</given-names></name>, <name><surname>Jain</surname><given-names>P</given-names></name>, <name><surname>Munsamy</surname><given-names>V</given-names></name>, <name><surname>Wolf</surname><given-names>A</given-names></name>, <name><surname>Karim</surname><given-names>F</given-names></name>, <etal>et al</etal>. <article-title>A Novel Reporter Phage To Detect Tuberculosis and Rifampin Resistance in a High-HIV-Burden Population</article-title>. <source>J Clin Microbiol</source>. <year>2015</year>;<volume>53</volume>(<issue>7</issue>):<fpage>2188</fpage>–<lpage>94</lpage>. Epub 2015/05/01. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JCM.03530-14</pub-id> ; PubMed Central PMCID: PMC4473227.<?supplied-pmid 25926493?><pub-id pub-id-type="pmid">25926493</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref094">
      <label>94</label>
      <mixed-citation publication-type="book"><name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>. <source><italic toggle="yes">Mycobacterium tuberculosis</italic>: A Once Genetically Intractable Organism</source>. In: <name><surname>Hatfull</surname><given-names>GF</given-names></name>, <name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, editors. <part-title>Molecular Genetics of the Mycobacteria.</part-title><publisher-loc>Washington, DC</publisher-loc>: <publisher-name>ASM Press</publisher-name>; <year>2000</year>. p. <fpage>1</fpage>–<lpage>16</lpage>.</mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref095">
      <label>95</label>
      <mixed-citation publication-type="journal"><name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <name><surname>Snapper</surname><given-names>SB</given-names></name>, <name><surname>Lugosi</surname><given-names>L</given-names></name>, <name><surname>Jekkel</surname><given-names>A</given-names></name>, <name><surname>Melton</surname><given-names>RE</given-names></name>, <name><surname>Kieser</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Development of genetic systems for the mycobacteria</article-title>. <source>Acta Leprol</source>. <year>1989</year>;<volume>7</volume>(<issue>Suppl 1</issue>):<fpage>203</fpage>–<lpage>7</lpage>. <?supplied-pmid 2503991?><pub-id pub-id-type="pmid">2503991</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref096">
      <label>96</label>
      <mixed-citation publication-type="journal"><name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <name><surname>Snapper</surname><given-names>SB</given-names></name>, <name><surname>Tuckman</surname><given-names>M</given-names></name>, <name><surname>Bloom</surname><given-names>BR</given-names></name>. <article-title>Mycobacteriophage vector systems</article-title>. <source>Rev Infect Dis</source>. <year>1989</year>;<volume>11</volume>(<issue>Suppl 2</issue>):<fpage>S404</fpage>–<lpage>10</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/clinids/11.supplement_2.s404</pub-id><?supplied-pmid 2652256?><pub-id pub-id-type="pmid">2652256</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref097">
      <label>97</label>
      <mixed-citation publication-type="journal"><name><surname>Ramakrishnan</surname><given-names>T</given-names></name>, <name><surname>Shaila</surname><given-names>MS</given-names></name>. <article-title>Interfamilial transfer of amber suppressor gene for the isolation of amber mutants of Mycobacteriophage I3</article-title>. <source>Arch Microbiol</source>. <year>1979</year>;<volume>120</volume>(<issue>3</issue>):<fpage>301</fpage>–<lpage>2</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/BF00423080</pub-id><?supplied-pmid 443992?><pub-id pub-id-type="pmid">443992</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref098">
      <label>98</label>
      <mixed-citation publication-type="journal"><name><surname>Raj</surname><given-names>CV</given-names></name>, <name><surname>Ramakrishnan</surname><given-names>T</given-names></name>. <article-title>Transduction in Mycobacterium smegmatis</article-title>. <source>Nature</source>. <year>1970</year>;<volume>228</volume>(<issue>268</issue>):<fpage>280</fpage>–<lpage>1</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/228280b0</pub-id><?supplied-pmid 5479524?><pub-id pub-id-type="pmid">5479524</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref099">
      <label>99</label>
      <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>S</given-names></name>, <name><surname>Kriakov</surname><given-names>J</given-names></name>, <name><surname>Vilcheze</surname><given-names>C</given-names></name>, <name><surname>Dai</surname><given-names>Z</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>, <name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>. <article-title>Bxz1, a new generalized transducing phage for mycobacteria</article-title>. <source>FEMS Microbiol Lett</source>. <year>2004</year>;<volume>241</volume>(<issue>2</issue>):<fpage>271</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.femsle.2004.10.032</pub-id> .<?supplied-pmid 15598543?><pub-id pub-id-type="pmid">15598543</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref100">
      <label>100</label>
      <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>MH</given-names></name>, <name><surname>Pascopella</surname><given-names>L</given-names></name>, <name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guerin</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1991</year>;<volume>88</volume>(<issue>8</issue>):<fpage>3111</fpage>–<lpage>5</lpage>. Epub 1991/04/25. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.88.8.3111</pub-id> ; PubMed Central PMCID: PMC51395.<?supplied-pmid 1901654?><pub-id pub-id-type="pmid">1901654</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref101">
      <label>101</label>
      <mixed-citation publication-type="journal"><name><surname>Parish</surname><given-names>T</given-names></name>, <name><surname>Lewis</surname><given-names>J</given-names></name>, <name><surname>Stoker</surname><given-names>NG</given-names></name>. <article-title>Use of the mycobacteriophage L5 excisionase in <italic toggle="yes">Mycobacterium tuberculosis</italic> to demonstrate gene essentiality</article-title>. <source>Tuberculosis (Edinb).</source><year>2001</year>;<volume>81</volume>(<issue>5–6</issue>):<fpage>359</fpage>–<lpage>64</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1054/tube.2001.0312</pub-id> .<?supplied-pmid 11800587?><pub-id pub-id-type="pmid">11800587</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref102">
      <label>102</label>
      <mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>P</given-names></name>, <name><surname>Marinelli</surname><given-names>LJ</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Hendrix</surname><given-names>RW</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Genomic characterization of mycobacteriophage Giles: evidence for phage acquisition of host DNA by illegitimate recombination</article-title>. <source>J Bacteriol</source>. <year>2008</year>;<volume>190</volume>(<issue>6</issue>):<fpage>2172</fpage>–<lpage>82</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/JB.01657-07</pub-id> .<?supplied-pmid 18178732?><pub-id pub-id-type="pmid">18178732</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref103">
      <label>103</label>
      <mixed-citation publication-type="journal"><name><surname>van Kessel</surname><given-names>JC</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Recombineering in <italic toggle="yes">Mycobacterium tuberculosis</italic></article-title>. <source>Nat Methods</source>. <year>2007</year>;<volume>4</volume>(<issue>2</issue>):<fpage>147</fpage>–<lpage>52</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nmeth996</pub-id> .<?supplied-pmid 17179933?><pub-id pub-id-type="pmid">17179933</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref104">
      <label>104</label>
      <mixed-citation publication-type="journal"><name><surname>van Kessel</surname><given-names>JC</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Efficient point mutagenesis in mycobacteria using single-stranded DNA recombineering: characterization of antimycobacterial drug targets</article-title>. <source>Mol Microbiol</source>. <year>2008</year>;<volume>67</volume>(<issue>5</issue>):<fpage>1094</fpage>–<lpage>107</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06109.x</pub-id> .<?supplied-pmid 18221264?><pub-id pub-id-type="pmid">18221264</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref105">
      <label>105</label>
      <mixed-citation publication-type="journal"><name><surname>van Kessel</surname><given-names>JC</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Mycobacterial recombineering.</article-title><source>Methods Mol Biol</source>. <year>2008</year>;<volume>435</volume>:<fpage>203</fpage>–<lpage>15</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/978-1-59745-232-8_15</pub-id> .<?supplied-pmid 18370078?><pub-id pub-id-type="pmid">18370078</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref106">
      <label>106</label>
      <mixed-citation publication-type="journal"><name><surname>van Kessel</surname><given-names>JC</given-names></name>, <name><surname>Marinelli</surname><given-names>LJ</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Recombineering mycobacteria and their phages</article-title>. <source>Nat Rev Microbiol</source>. <year>2008</year>;<volume>6</volume>(<issue>11</issue>):<fpage>851</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrmicro2014</pub-id> .<?supplied-pmid 18923412?><pub-id pub-id-type="pmid">18923412</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref107">
      <label>107</label>
      <mixed-citation publication-type="journal"><name><surname>Court</surname><given-names>DL</given-names></name>, <name><surname>Sawitzke</surname><given-names>JA</given-names></name>, <name><surname>Thomason</surname><given-names>LC</given-names></name>. <article-title>Genetic engineering using homologous recombination</article-title>. <source>Annu Rev Genet</source>. <year>2002</year>;<volume>36</volume>:<fpage>361</fpage>–<lpage>88</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1146/annurev.genet.36.061102.093104</pub-id> .<?supplied-pmid 12429697?><pub-id pub-id-type="pmid">12429697</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref108">
      <label>108</label>
      <mixed-citation publication-type="journal"><name><surname>Datsenko</surname><given-names>KA</given-names></name>, <name><surname>Wanner</surname><given-names>BL</given-names></name>. <article-title>One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2000</year>;<volume>97</volume>(<issue>12</issue>):<fpage>6640</fpage>–<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id> .<?supplied-pmid 10829079?><pub-id pub-id-type="pmid">10829079</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref109">
      <label>109</label>
      <mixed-citation publication-type="journal"><name><surname>Murphy</surname><given-names>KC</given-names></name>, <name><surname>Nelson</surname><given-names>SJ</given-names></name>, <name><surname>Nambi</surname><given-names>S</given-names></name>, <name><surname>Papavinasasundaram</surname><given-names>K</given-names></name>, <name><surname>Baer</surname><given-names>CE</given-names></name>, <name><surname>Sassetti</surname><given-names>CM</given-names></name>. <article-title>ORBIT: a New Paradigm for Genetic Engineering of Mycobacterial Chromosomes.</article-title><source>MBio</source>. <year>2018</year>;<volume>9</volume>(<issue>6</issue>). Epub 2018/12/13. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.01467-18</pub-id> ; PubMed Central PMCID: PMC6299477.<?supplied-pmid 30538179?><pub-id pub-id-type="pmid">30538179</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref110">
      <label>110</label>
      <mixed-citation publication-type="journal"><name><surname>Marinelli</surname><given-names>LJ</given-names></name>, <name><surname>Piuri</surname><given-names>M</given-names></name>, <name><surname>Swigonova</surname><given-names>Z</given-names></name>, <name><surname>Balachandran</surname><given-names>A</given-names></name>, <name><surname>Oldfield</surname><given-names>LM</given-names></name>, <name><surname>van Kessel</surname><given-names>JC</given-names></name>, <etal>et al</etal>. <article-title>BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes.</article-title><source>PLoS ONE</source>. <year>2008</year>;<volume>3</volume>(<issue>12</issue>):<fpage>e3957</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0003957</pub-id> .<?supplied-pmid 19088849?><pub-id pub-id-type="pmid">19088849</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref111">
      <label>111</label>
      <mixed-citation publication-type="journal"><name><surname>Marinelli</surname><given-names>LJ</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>, <name><surname>Piuri</surname><given-names>M</given-names></name>. <article-title>Recombineering: A powerful tool for modification of bacteriophage genomes.</article-title><source>Bacteriophage</source>. <year>2012</year>;<volume>2</volume>(<issue>1</issue>):<fpage>5</fpage>–<lpage>14</lpage>. Epub 2012/06/06. <comment>doi: </comment><pub-id pub-id-type="doi">10.4161/bact.18778</pub-id> 2011BACTERIOPHAGE0041R [pii]. ; PubMed Central PMCID: PMC3357384.<?supplied-pmid 22666652?><pub-id pub-id-type="pmid">22666652</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref112">
      <label>112</label>
      <mixed-citation publication-type="journal"><name><surname>Marinelli</surname><given-names>LJ</given-names></name>, <name><surname>Piuri</surname><given-names>M</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Genetic Manipulation of Lytic Bacteriophages with BRED: Bacteriophage Recombineering of Electroporated DNA.</article-title><source>Methods Mol Biol</source>. <year>2019</year>;<volume>1898</volume>:<fpage>69</fpage>–<lpage>80</lpage>. Epub 2018/12/21. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/978-1-4939-8940-9_6</pub-id> .<?supplied-pmid 30570724?><pub-id pub-id-type="pmid">30570724</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref113">
      <label>113</label>
      <mixed-citation publication-type="journal"><name><surname>Wetzel</surname><given-names>KS</given-names></name>, <name><surname>Guerrero-Bustamante</surname><given-names>CA</given-names></name>, <name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Ko</surname><given-names>CC</given-names></name>, <name><surname>Freeman</surname><given-names>KG</given-names></name>, <name><surname>Aull</surname><given-names>HG</given-names></name>, <etal>et al</etal>. <article-title>CRISPY-BRED and CRISPY-BRIP: efficient bacteriophage engineering.</article-title><source>Sci Rep.</source><year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>6796</fpage>. Epub 2021/03/26. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-021-86112-6</pub-id> ; PubMed Central PMCID: PMC7990910.<?supplied-pmid 33762639?><pub-id pub-id-type="pmid">33762639</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref114">
      <label>114</label>
      <mixed-citation publication-type="journal"><name><surname>Housby</surname><given-names>JN</given-names></name>, <name><surname>Mann</surname><given-names>NH</given-names></name>. <article-title>Phage therapy.</article-title><source>Drug Discov Today</source>. <year>2009</year>;<volume>14</volume>(<issue>11–12</issue>):<fpage>536</fpage>–<lpage>40</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.drudis.2009.03.006</pub-id> .<?supplied-pmid 19508915?><pub-id pub-id-type="pmid">19508915</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref115">
      <label>115</label>
      <mixed-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Smith</surname><given-names>BE</given-names></name>, <name><surname>Cristinziano</surname><given-names>M</given-names></name>, <name><surname>Freeman</surname><given-names>KG</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Belessis</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease</article-title>. <source>Clin Infect Dis</source>. <year>2022</year>; Forthcoming.</mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref116">
      <label>116</label>
      <mixed-citation publication-type="journal"><name><surname>Nick</surname><given-names>JA</given-names></name>, <name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Gray</surname><given-names>AL</given-names></name>, <name><surname>Vladar</surname><given-names>EK</given-names></name>, <name><surname>Smith</surname><given-names>BE</given-names></name>, <name><surname>Freeman</surname><given-names>KG</given-names></name>, <etal>et al</etal>. <article-title>Host and Pathogen Response to Bacteriophage Engineered Against Mycobacterium abscessus Lung Infection</article-title>. <source>Cell</source>. <year>2022</year>; Forthcoming. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2022.04.024</pub-id><?supplied-pmid 35568033?><pub-id pub-id-type="pmid">35568033</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref117">
      <label>117</label>
      <mixed-citation publication-type="journal"><name><surname>Little</surname><given-names>JS</given-names></name>, <name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Freeman</surname><given-names>KG</given-names></name>, <name><surname>Cristinziano</surname><given-names>M</given-names></name>, <name><surname>Smith</surname><given-names>BE</given-names></name>, <name><surname>Benson</surname><given-names>CA</given-names></name>, <etal>et al</etal>. <article-title>Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection.</article-title><source>Nat Commun.</source><year>2022</year>;<volume>13</volume>(<issue>1</issue>):<fpage>2313</fpage>. Epub 2022/05/04. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41467-022-29689-4</pub-id> ; PubMed Central PMCID: PMC9064978.<?supplied-pmid 35504908?><pub-id pub-id-type="pmid">35504908</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref118">
      <label>118</label>
      <mixed-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Freeman</surname><given-names>KG</given-names></name>, <name><surname>Nguyen</surname><given-names>JA</given-names></name>, <name><surname>Bahadirli-Talbott</surname><given-names>A</given-names></name>, <name><surname>Smith</surname><given-names>BE</given-names></name>, <name><surname>Wu</surname><given-names>AE</given-names></name>, <etal>et al</etal>. <article-title>Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection</article-title>. <source>Nat Med</source>. <year>2021</year>;<volume>27</volume>(<issue>8</issue>):<fpage>1357</fpage>–<lpage>61</lpage>. Epub 2021/07/10. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41591-021-01403-9</pub-id> .<?supplied-pmid 34239133?><pub-id pub-id-type="pmid">34239133</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref119">
      <label>119</label>
      <mixed-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Freeman</surname><given-names>KG</given-names></name>, <name><surname>Nguyen</surname><given-names>JA</given-names></name>, <name><surname>Bahadirli-Talbott</surname><given-names>A</given-names></name>, <name><surname>Cardin</surname><given-names>ME</given-names></name>, <name><surname>Cristinziano</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Nebulized bacteriophage in a patient with refractory Mycobacterium abscessus lung disease</article-title>. <source>Open Forum Infect Dis</source>. <year>2022</year>; Forthcoming.</mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref120">
      <label>120</label>
      <mixed-citation publication-type="journal"><name><surname>Trigo</surname><given-names>G</given-names></name>, <name><surname>Martins</surname><given-names>TG</given-names></name>, <name><surname>Fraga</surname><given-names>AG</given-names></name>, <name><surname>Longatto-Filho</surname><given-names>A</given-names></name>, <name><surname>Castro</surname><given-names>AG</given-names></name>, <name><surname>Azeredo</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model.</article-title><source>PLoS Negl Trop Dis</source>. <year>2013</year>;<volume>7</volume>(<issue>4</issue>):<fpage>e2183</fpage>. Epub 2013/05/03. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pntd.0002183</pub-id> ; PubMed Central PMCID: PMC3636042.<?supplied-pmid 23638204?><pub-id pub-id-type="pmid">23638204</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref121">
      <label>121</label>
      <mixed-citation publication-type="book"><name><surname>Hatfull</surname><given-names>GF</given-names></name>. <source>Mycobacteriophages and tuberculosis</source>. In: <name><surname>Eisenach</surname><given-names>K</given-names></name>, <name><surname>Cole</surname><given-names>ST</given-names></name>, <name><surname>Jacobs</surname><given-names>WR</given-names><suffix>Jr</suffix></name>, <name><surname>McMurray</surname><given-names>D</given-names></name>, editors. <part-title>Tuberculosis.</part-title><publisher-loc>Washington, DC</publisher-loc>: <publisher-name>ASM Press</publisher-name>; <year>2004</year>. p. <fpage>203</fpage>–<lpage>18</lpage>.</mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref122">
      <label>122</label>
      <mixed-citation publication-type="journal"><name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Mycobacteriophages: windows into tuberculosis</article-title>. <source>PLoS Pathog</source>. <year>2014</year>;<volume>10</volume>(<issue>3</issue>):<fpage>e1003953</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.ppat.1003953</pub-id> ; PubMed Central PMCID: PMC3961340.<?supplied-pmid 24651299?><pub-id pub-id-type="pmid">24651299</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref123">
      <label>123</label>
      <mixed-citation publication-type="journal"><name><surname>Diacon</surname><given-names>AH</given-names></name>, <name><surname>Guerrero-Bustamante</surname><given-names>CA</given-names></name>, <name><surname>Rosenkranz</surname><given-names>B</given-names></name>, <name><surname>Rubio Pomar</surname><given-names>FJ</given-names></name>, <name><surname>Vanker</surname><given-names>N</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>. <article-title>Mycobacteriophages to Treat Tuberculosis: Dream or Delusion?</article-title><source>Respiration</source>. <year>2022</year>;<volume>101</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>15</lpage>. Epub 2021/11/24. <comment>doi: </comment><pub-id pub-id-type="doi">10.1159/000519870</pub-id> .<?supplied-pmid 34814151?><pub-id pub-id-type="pmid">34814151</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref124">
      <label>124</label>
      <mixed-citation publication-type="journal"><name><surname>Shield</surname><given-names>CG</given-names></name>, <name><surname>Swift</surname><given-names>BMC</given-names></name>, <name><surname>McHugh</surname><given-names>TD</given-names></name>, <name><surname>Dedrick</surname><given-names>RM</given-names></name>, <name><surname>Hatfull</surname><given-names>GF</given-names></name>, <name><surname>Satta</surname><given-names>G</given-names></name>. <article-title>Application of Bacteriophages for Mycobacterial Infections, from Diagnosis to Treatment.</article-title><source>Microorganisms.</source><year>2021</year>;<volume>9</volume>(<issue>11</issue>). Epub 2021/11/28. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/microorganisms9112366</pub-id> ; PubMed Central PMCID: PMC8617706.<?supplied-pmid 34835491?><pub-id pub-id-type="pmid">34835491</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref125">
      <label>125</label>
      <mixed-citation publication-type="journal"><name><surname>Broxmeyer</surname><given-names>L</given-names></name>, <name><surname>Sosnowska</surname><given-names>D</given-names></name>, <name><surname>Miltner</surname><given-names>E</given-names></name>, <name><surname>Chacon</surname><given-names>O</given-names></name>, <name><surname>Wagner</surname><given-names>D</given-names></name>, <name><surname>McGarvey</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens</article-title>. <source>J Infect Dis</source>. <year>2002</year>;<volume>186</volume>(<issue>8</issue>):<fpage>1155</fpage>–<lpage>60</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1086/343812</pub-id> .<?supplied-pmid 12355367?><pub-id pub-id-type="pmid">12355367</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref126">
      <label>126</label>
      <mixed-citation publication-type="journal"><name><surname>Danelishvili</surname><given-names>L</given-names></name>, <name><surname>Young</surname><given-names>LS</given-names></name>, <name><surname>Bermudez</surname><given-names>LE</given-names></name>. <article-title>In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacterium</article-title>. <source>Microb Drug Resist</source>. <year>2006</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1089/mdr.2006.12.1</pub-id> .<?supplied-pmid 16584300?><pub-id pub-id-type="pmid">16584300</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref127">
      <label>127</label>
      <mixed-citation publication-type="journal"><name><surname>Foley-Thomas</surname><given-names>EM</given-names></name>, <name><surname>Whipple</surname><given-names>DL</given-names></name>, <name><surname>Bermudez</surname><given-names>LE</given-names></name>, <name><surname>Barletta</surname><given-names>RG</given-names></name>. <article-title>Phage infection, transfection and transformation of Mycobacterium avium complex and Mycobacterium paratuberculosis</article-title>. <source>Microbiology</source>. <year>1995</year>;<volume>141</volume>(<issue>Pt 5</issue>):<fpage>1173</fpage>–<lpage>81</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1099/13500872-141-5-1173</pub-id><?supplied-pmid 7773411?><pub-id pub-id-type="pmid">7773411</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref128">
      <label>128</label>
      <mixed-citation publication-type="journal"><name><surname>Gorski</surname><given-names>A</given-names></name>, <name><surname>Miedzybrodzki</surname><given-names>R</given-names></name>, <name><surname>Borysowski</surname><given-names>J</given-names></name>, <name><surname>Dabrowska</surname><given-names>K</given-names></name>, <name><surname>Wierzbicki</surname><given-names>P</given-names></name>, <name><surname>Ohams</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Phage as a modulator of immune responses: practical implications for phage therapy</article-title>. <source>Adv Virus Res</source>. <year>2012</year>;<volume>83</volume>:<fpage>41</fpage>–<lpage>71</lpage>. Epub 2012/07/04. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/B978-0-12-394438-2.00002-5</pub-id> .<?supplied-pmid 22748808?><pub-id pub-id-type="pmid">22748808</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref129">
      <label>129</label>
      <mixed-citation publication-type="journal"><name><surname>Nguyen</surname><given-names>S</given-names></name>, <name><surname>Baker</surname><given-names>K</given-names></name>, <name><surname>Padman</surname><given-names>BS</given-names></name>, <name><surname>Patwa</surname><given-names>R</given-names></name>, <name><surname>Dunstan</surname><given-names>RA</given-names></name>, <name><surname>Weston</surname><given-names>TA</given-names></name>, <etal>et al</etal>. <article-title>Bacteriophage Transcytosis Provides a Mechanism To Cross Epithelial Cell Layers.</article-title><source>MBio</source>. <year>2017</year>;<volume>8</volume>(<issue>6</issue>). Epub 2017/11/23. <comment>doi: </comment><pub-id pub-id-type="doi">10.1128/mBio.01874-17</pub-id> ; PubMed Central PMCID: PMC5698557.<?supplied-pmid 29162715?><pub-id pub-id-type="pmid">29162715</pub-id></mixed-citation>
    </ref>
    <ref id="ppat.1010602.ref130">
      <label>130</label>
      <mixed-citation publication-type="journal"><name><surname>Freeman</surname><given-names>KG</given-names></name>, <name><surname>Wetzel</surname><given-names>KS</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Zack</surname><given-names>KM</given-names></name>, <name><surname>Jacobs-Sera</surname><given-names>D</given-names></name>, <name><surname>Walters</surname><given-names>SM</given-names></name>, <etal>et al</etal>. <article-title>A Mycobacteriophage-Based Vaccine Platform: SARS-CoV-2 Antigen Expression and Display.</article-title><source>Microorganisms</source>. <year>2021</year>;<volume>9</volume>(<issue>12</issue>). Epub 2021/12/25. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/microorganisms9122414</pub-id> ; PubMed Central PMCID: PMC8704799.<?supplied-pmid 34946016?><pub-id pub-id-type="pmid">34946016</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
